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Objective. This pilot study sought to quantitatively evaluate quality of life changes among patients of 
substance use disorder (SUD) treatment  institutions following participation in coach-led exercise 
groups. The pilot  study also intended to use attendance data and qualitative feedback to assess the 
feasibility of such an exercise intervention and discuss the potentiality for scaling it up as a larger, 
adjunct therapeutic intervention. 
Methods. 35 residents of four post-acute SUD treatment institutions enrolled in ten-week, low-
intensity exercise groups that  met for three days each week in half-hour sessions. Before and after the 
intervention, participants answered the World Health Organization’s Quality of Life Brief 
(WHOQOL-BREF), the Hopkins Symptom Checklist  (HSCL-25), and self-report inventories 
modified from the Norwegian Follow-up Study for Opioid Dependents that  measured current 
substance use and somatic burden. Those who enrolled and exercised were analyzed as exercisers, 
and those who enrolled but  did not  exercise were analyzed as non-exercisers. Quantitative data on 
attendance was integrated with qualitative feedback from participants and coaches to evaluate 
program acceptability and feasibility. 
Results. Physical health quality of life and psychological health quality of life increased with 
statistical and clinical significance among exercisers, but  not  among non-exercisers. Exercise had no 
impact  on participants’ social relationships quality of life or environment quality of life. Participants 
with clinical levels of emotional distress were more likely to exercise than those with sub-clinical 
levels, as were participants with a greater burden of somatic health problems. Coaches held important 
roles as motivators in order to engage participants and make the groups accessible. 
Conclusion. This pilot study has provided novel, preliminary evidence of quantitative quality of life 
gains as a result  of participation in a coach-led group exercise intervention. Several design elements 
have been identified for future interventions to replicate and improve upon, such as those that helped 
engage the most physically and mentally vulnerable participants.
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(QoL)
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71.	  Introduc9on
1.1	  Study	  relevance
The prevalence and seriousness of substance use disorders (SUD) is a social problem 
that has repercussions far beyond the individuals affected. The manners in which countries 
choose to treat – in both the legal and social meanings of the word – persons with SUD can 
lend to their recovery or not. When a person does receive medical or behavioral treatment, 
recovery as defined by  abstinence is a sparse outcome; relapse rates worldwide are between 
60-90% in the first year after treatment [1]. 
Two important developments in the SUD treatment field have influenced this pilot 
study: first, the inclusion of outcomes within the concept of recovery besides abstinence, 
particular quality of life (QoL); and second, an interest  in adjunct and/or alternative 
treatments that focus on improving some of the many physical, mental, and social 
comorbidities of SUD.
I used promising, pre-clinical research on animals and exercise, best practices from 
exercise interventions with SUD and other clinical populations, and my own experiences 
coaching to design an exercise-based intervention for SUD patients in Oslo. I hope that the 
knowledge arising from this pilot study will provide preliminary evidence as to the efficacy 
and replicability of an exercise intervention to increase QoL, and that I can provide both 
Norwegian and American practitioners with modest best practices. 
1.2	  Research	  aims
This thesis sought to design and implement, based on best practices from behavioral 
interventions with SUD patients and exercise interventions among other populations, an 
adjunct treatment of group exercise for SUD patients, then to measure whether participants 
experienced changes in their QoL. It is hypothesized that the physical health and social 
relationships domains of QoL will increase in a dose-response relationship to the amount of 
participation.
Specific aims include: 
1. To describe quality of life and clinical variables of this sample of SUD patients, 
including differences between exercisers and non-exercisers. 
82. To evaluate changes in domain-specific QoL following the pilot study among the 
exercise and non-exercise groups. To determine if exercise changed any domains of 
QoL, and if changes were clinically meaningful.  
3. To discuss possible explanatory factors associated with QoL changes.
4. To evaluate the feasibility and replicability  of this exercise intervention by analyzing 
who the group appealed to and which activities and factors increased attendance, and 
document best practices to help improve the design and reduce the attrition rates of a 
future, larger intervention. 
1.3	  Substance	  use	  disorders
1.3.1	  Defini9on
The term “substance use disorders” (SUD) encompasses substance dependence, 
harmful or problematic use, and abuse. The World Health Organization’s International 
Classification of Diseases (ICD-10) includes as SUD both substance dependence and 
harmful use, while the American-produced Diagnostic and Statistical Manual of Mental 
Disorders (DSM-V) recently removed its separation of dependence and abuse from a SUD 
diagnosis [2-4]. In the WHO’s Global Burden of Disease report, discussed below, abuse of 
illicit drugs is called problematic use. 
A diagnosis of a SUD according to either definition is made when a patient presents 
with at least two (DSM-V) or three (ICD-10) symptoms out of a possible seven (ICD-10) or 
nine (DSM-V). Both definitions include as symptoms risky use/behavior, impaired control, 
and pharmacological criteria such as tolerance and withdrawal. The ICD-10’s “abuse” 
symptom is evidenced by “physical or psychological harm, which may lead to disability/
adverse consequences”. The DSM-V additionally includes “social impairment”, which the 
ICD-10 has omitted on the grounds that social consequences are culture-specific and a SUD 
diagnosis should be as globally relevant as possible [2]. 
The legality or illegality of the substance is not of importance to diagnostic criteria; 
rather, symptoms represent recognized impacts of substance use on mental health and 
psychosocial functioning [5].
1.3.2	  Prevalence	  and	  popula9on	  effect
The number of persons suffering worldwide from SUD is unknown, but the World 
Health Organization’s latest estimation of alcohol use disorder prevalence by  region ranges 
9from <1% in Africa to 16% in Eastern Europe [6]. Regional prevalence rates for drug use 
disorders are estimated to be far lower, from <1% in China, India, and Eastern Europe, to 
3% in Eastern Mediterranean countries. The SUD population differs slightly in Norway and 
in the United States. At any given time, 9% of men in Norway have an alcohol use disorder, 
compared with 2.5% of women, while 0.4% of men and 0.1% of women have a drug use 
disorder and 0.14%. These numbers are 5.5% and 2% for alcohol use disorders and 1.8% and 
0.6% for drug use disorders in the U.S. [7]. Prevalence is consistently higher for men than 
women, on a magnitude of seven to three globally for all SUD [6]. 
Another method exists to quantify  the impact of SUD on human life: the Global 
Burden of Disease estimates the loss of healthy  life years due to injury and illness by 
measuring both years loss to death and years spent disabled, resulting in a single, negative 
measure of disability-adjusted life years (DALY). Mental disorders and SUD account for 
7.4% of the global burden of disease and are the fifth-largest category of DALYs. Among 
this group, SUD are the second most common cause of DALYs (20.5%), following only 
depressive disorders (40.5%) [8].  Nearly 13 DALYs per 1000 globally are due to SUD, of 
which 11 are due to alcohol and 2 to illicit drugs (although only opioid and cocaine are 
included, and Degenhardt interprets the same GBD data to suggest that  drug use disorders 
account for at least as many DALYs as alcohol use disorders in high-income countries [9]). 
Europe has the highest regional amount of DALYs (23), followed by the Americas (18) [6]. 
1.3.3	  Comorbidi9es
There are a number of mental and physical comorbidities associated with SUD. The 
label “co-occurring disorders” applies to the majority of persons with SUD who also have a 
mental health disorder (see Flynn and Brown for a review of American and international 
studies confirming these numbers [10]). SUD patients presenting for treatment display, at 
most estimates, an even higher prevalence of co-occurring disorders. The two most common 
are depressive and anxiety disorders followed by personality disorders and stress-related 
disorders [11-13]; the prevalence of these disorders has been verified among Norwegian 
patients by Ravndal and Lauritzen [14]. 
 Physical comorbidities are also well-documented. Kearney  et al’s research in London 
found that 76% of SUD inpatients and outpatients received at least one physical health 
problem diagnosis at treatment entry, 51% received at least two, and 31% received three or 
more. Nearly half of the sample received diagnoses rated “moderate” or “severe”, as 
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assessed by the Health Morbidity Scale; the most common moderately/severe problems were 
cardiovascular, gastrointestinal, liver, and neurological [15]. De Alba’s study  of SUD 
patients in Boston found that half of all presenting patients had no primary care relationship, 
and that these patients had a higher burden of illness and worse physical health compared to 
the general population. Even excluding those with psychiatric comorbidities, these SUD 
patients had double the incidence rates of pneumonia, COPD, hypertension, stroke, and 
diabetes [16]. Sæland reports the magnification of certain physical comorbidities such as 
malnutrition and being underweight when persons with a SUD are not in treatment [17, 18].
Sæland also argues against the generally accepted opinion that the poor health of 
persons with a SUD (either in or out of treatment) is due mainly to their substance use [19], 
a type of blame-the-user approach that often underpins social unwillingness to provide a 
fuller breadth of treatments.  She approaches health status from a nutritional and dietary 
point of view and asserts that a lack of access to food, particularly  to nutritional food, 
homelessness, and sickness or pathological conditions that lead to nausea or other difficulties 
eating all lead to health conditions that should be considered as independent to SUD. 
Connections between nutrition, food content, and diet, “if neglected, can function as counter-
productive forces in rehabilitation and treatment efforts.” 
 Pursuant to SUD patients’ worse overall physical health, multiple studies have found 
SUD patients to have lower level of aerobic fitness compared to the general population. 
Mamen and Martinsen [20] provide of a review of those studies indirectly measuring VO2max 
(maximal oxygen uptake) and lactate threshold (the amount of physical activity one can 
undertake before the body produces lactic acid) [21]. Both tests measure endurance capacity, 
and VO2max additionally measures aerobic capacity. 
 It is the interaction of SUD, mental health, and physical comorbidities that perhaps 
presents the greatest challenges in diagnoses, treatment, and outcome measurement. A 
national, longitudinal study in Finland found that 99% of SUD patients had either a physical 
comorbidity  or a mental comorbidity [22]. Frasch reviews the physical comorbidities [23] 
associated with different substances among patients with both a SUD and psychiatric 
diagnosis: alcohol use is linked with injuries, diabetes, hypertension, coronary heart disease, 
and various cancers; cannabis and tobacco use with many chronic, high-mortality respiratory 
and cardiovascular diseases; injection drug use with tuberculosis, viral hepatitis, HIV, and 
skin and soft tissue infections; cocaine use with myocardial infarction and other heart 
complications; and amphetamine use with cardiac arrhythmia, stroke, renal failure, and 
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hyperthermia. These comorbidities influence and interact with each other in ways that stifle 
efforts at siloed treatment. For example, Tripp found that physical health predicts treatment 
outcome for SUD patients with a depressive diagnosis [13]; physical health therefore must 
be treated on par with these patients’ other diagnoses. 
1.3.4	  E9ology
Researchers’, policy makers’, and practitioners’ understandings of the etiology  of a 
SUD, described as “models of addiction”, influence their development and defense of 
various treatment models and the outcomes measured after those treatments. The Principles 
of Addiction [24-27] provides a thorough overview of different addiction modes, of which I 
will highlight the most currently relevant and link to associated treatment models. 
The moral model is perhaps the original understanding of addiction, and has no 
empirical support. Persons choose to use, abuse, and be addicted to a substance, and they  can 
also choose to stop. Treatment, if one can call it that, is comprised simply  of a person willing 
themselves into abstinence, and those who choose to continue substance use can be 
condemned as weak and immoral. The next historical development was the enlightenment/
spiritual model, represented by Alcoholics Anonymous and its Twelve-Step  program towards 
lasting sobriety. Substance users are responsible for the development of their addiction, but 
not for recovery; only submission and discipline to the authority  of a higher, external power 
enables recovery. 
The medical/disease model, in which we meet the term “substance use disorder”, 
responds to the moral and enlightenment models by  removing both substance use 
development and recovery from the individual’s responsibility, and by instead using 
scientific inquiry to define what was heretofore known only as problematic behavior. This is 
the model employed by the DSM-V, ICD-10, and the medical communities that created 
them, and while still evolving to include causes, particularly  neurological, at its simplest 
defines a SUD as a chronic disease – a physiological pathology – underpinned by biological 
causes or predispositions that are deviations from the norm. Preclinical and clinical 
neurological research points towards the mesolimbic dopamine pathway as the reward- and 
emotion-mediating region of the brain, prospectively assessing both positive and negative 
experiences via the amygdala, hippocampus, prefrontal cortex, and orbitofrontal cortex [28, 
29]. Early neurobiological exploration of SUD established that substance use increased 
dopamine transmission and thereby created a compulsive drive for further use [29], while 
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more recent research suggests that the sections of the mesolimbic region responsible for 
restraining impulsivity  are also compromised among SUD patients [28, 30, 31]. Substances 
appear to act, via direct and indirect changes in dopamine transmission, in ways that increase 
activity in the impulsive system and decrease activity in the executive/inhibitory system. 
SUD-related behaviors are indicators and symptoms: tolerance and withdrawal are 
seen as physiological symptoms and used to measure the severity of a SUD, while cravings 
and loss of control perpetuate a SUD. The medical model does not presuppose that SUD 
manifests only along biological dimensions, but acknowledges the social/behavioral, 
psychological, and spiritual dimensions as well, hence the increasing interest in outcome 
measurements beyond reduced or eliminated substance use (discussed further in 1.4 Quality 
of life). Both the DSM-V and ICD-10 include reduced or impaired social, family, or work 
functioning’s within diagnostic criteria for a SUD. 
Given the understanding of extra-biological factors’ involvement in the biochemical 
expression and development of SUD, Kincaid and Sullivan argue that the model espoused by 
the DSM-V and ICD-10 cannot be defended as a pure medical model [30]. A pure medical 
model would not include symptoms that rely  on social conventions, such as “important 
alternative pleasures or interests given up or reduced” [2], which, they assert, borrow from 
the social model of SUD, and it would contain at least  one diagnostically necessary physical 
condition. Indeed, much of how a SUD is understood to develop among the medical 
community  bears similarities to the biopsychosocial model, which claims to not overstate the 
importance of biological factors when considering how “biological, genetic, personality, 
psychological, cognitive, social, cultural, and environmental factors interact to produce the 
SUD”  [27]. The biopsychosocial model strives to include personality variables, learning 
conditions, cognitive processes regarding outcome expectancies and self-efficacy, peer and 
family pressure, and environmental factors as all equally important to the expression of a 
biologic predisposition to a SUD. 
Much of the criticism of the medical model from the biopsychosocial model camp is 
that the former fails to address multiple extra-biological factors in prevention and treatment 
programs [27]. For the purposes of this review, adherence to one or the other models is 
unnecessary. No researcher espousing a medical model understanding of a SUD denies the 
influences of, for example, substance availability (i.e. environment), and neither would she 
support a treatment program that did not in turn support a person in recovery from finding a 
sober-living house and undergoing cognitive-behavioral therapy. At the same time, 
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participants qualified for this pilot study in part by their treatment institution’s diagnosis of a 
SUD according to the ICD-10 (see 2.3 Sample).  
1.3.5	  Recovery
Treatment, Laudet reminds us, has as its number one priority the advancement of a 
SUD patient’s recovery [32]. But in light of the overlap  of the medical model’s neurological 
basis for SUD and the biopsychosocial model’s interest in psychological and social factors, it 
has proved problematic for researchers to decide what exactly recovery from SUD includes: 
abstinence, full or partial? Abstinence or reduced use of only the substance with which a 
patient received a SUD diagnosis, thereby allowing for medication-assisted therapy such as 
opioid replacement therapy, or from all psychoactive substances? Improvement in concurrent 
emotional, mental, or physical health? Improvement in any of the wide range of functions 
that are also negatively affected? Can recovery be achieved in gradients, or is it a complete 
state? As recently as 2007, White claimed in The Journal of Substance Abuse Treatment that 
claimed the SUD treatment field had no clear definition of “recovery”: 
It is not surprising in the face of such confusion that researchers tend to avoid the term, 
clinicians and mutual aid advocates use the term but with different meanings, and the public 
tends to understand recovery as an attempt to resolve, rather than the successful resolution of, 
[SUD]. [33]
The legacy of various etiological models of SUD are the treatment modals they employ, the 
post-treatment outcomes they measure, and particularly their definitions of recovery. The 
heavily-American moral model, advocated by the American medical establishment even 
after the failure of Prohibition, lead the World Health Organization to enshrine abstinence as 
necessary in recovery from alcoholism. Problematic substance use and recovery  were 
dichotomous states.
The World Health Organization performed a “complete turnabout” in policy in 1980, 
prompted by pressure from European countries to address the HIV/AIDS epidemic among 
injecting drug users [34]. The harm reduction strategy was developed as an alternative to 
abstinence-only treatment and with attention to reducing adverse consequences of SUD, 
including patient mortalities and morbidities, and on measuring social, economic, and health 
outcomes instead of substance consumption. Van Wormer suggests that a harm reduction 
approach reflects an understanding of substance use as existing on a continuum, rather than a 
clear line dividing normality  (health) from abnormality (SUD), and thereby relinquishing 
abstinence as a prerequisite of recovery. However, the UN Office on Drugs and Crimes is 
14
keen to support harm reduction as a strategy  for all definitions of recovery, “whether your 
organization agrees or not that the ultimate goal for substance use treatment should be 
abstinence, drug use control, or both” [35]. In the UNODC’s white paper on harm reduction 
– published after White’s charge that the concept of “recovery” is both avoided and poorly 
defined – this word is not used once. 
The US government’s evolving definition of recovery reflects the movement away 
from abstinence-as-prerequisite. Recovery according to the Substance Abuse and Mental 
Health Services Administration has been updated thrice since its 2005 definition of 
“abstinence and improved health, wellness, and quality of life” [36]. The first two revisions 
removed abstinence and defined recovery  as a “process of change”, and the final revision 
reintroduced abstinence as an example of an improvement in health. Recovery is now “a 
process of change through which individuals improve their health and wellness, live a self-
directed life, and strive to reach their full potential.” This process is supported by the 
dimensions of health (e.g. abstinence; overcoming or managing disease/s or symptoms/), 
home, purpose (including individually selected social roles), and community [37]. 
The Norwegian Directorate of Health describes recovery in a similarly  holistic 
manner, but does not mention abstinence: 
The goal is to find the patient's own resources when it comes to finding meaningful 
activities, getting a job, increase their social network, solving economic and housing needs, 
in order to increase quality of life and self-esteem. The person's own resources must be 
supported during the course of treatment in such a way to increase quality of life. (my 
translation) [38]
Recovery is defined by the Directorate as “the goal of overall improvement of quality  of 
life”. Operationally, the process of recovery is also central, and the importance of social 
support in this process is perhaps given more weight than in the United States. Researchers 
from the Norwegian Center for Addiction Research set out to define a model of recovery and 
developed a “positive identity model of change” that focuses on social support given from a 
supporter to a recoverer [39]. In this model, a person with a SUD recovers when, over time, 
the supporter and the recoverer create a context in which the recoverer can build a positive 
self-identity that the supporter is able to affirm: “Recovery programs should entail 
opportunities for personally meaningful activities that can be socially shared.” 
If SUD are understood as progressive and chronic (i.e. reoccurring) conditions [40, 
41], recovery can understandably be a process with a similarly long duration and perhaps 
cyclical achievement.
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1.3.6	  Salient	  outcomes	  of	  treatment	  effec9veness
Many researchers have pointed towards the empirical difficulties of measuring 
recovery. For example, medication-assisted recovery such as opioid replacement therapy 
illegitimates abstinence-only  recovery experiences. Only patients themselves can report 
improved quality of life or well-being, necessitating another layer of reporting. Thylstrup 
admits that  “the recovery  paradigm has thus been criticized for possibly contributing to the 
variability and confusion of outcome measures in substance abuse treatment” [42]. The 
addiction research field has not, as of yet, adopted any core set of outcomes [32, 43]. There 
is a further heterogeneity  of measures and methodology even within shared outcomes. 
Tiffany et al reproach researchers for this failing, saying that it not only discourages further 
attempts at  the adoption of a shared battery of outcomes/measures, but that it leads to an 
extreme amount of measures, and measurement decisions often occurring on a study-by-
study, ad hoc basis [43]. 
The most consistently reported primary outcome is abstinence or its inverse, 
substance use. Tiffany et al argue that this outcome is an insufficient measure by itself, 
because SUD have negative consequences that are not “tightly  coupled” to the amount of 
use. Interestingly, they suggest outcomes that Thylstrup  labels “traditional” and belonging to 
a pre-recovery-orientation, such as employment and crime. These outcomes are 
understandable to communities and represent easily  recognizable social consequences, and 
therefore may increase community  support. Emergency room visits are an example of a 
health-related outcome that is considered socially  salient. Other common health outcomes 
include reductions in depression or anxiety, other mood measurements, and a decrease in 
cravings. 
Tiffany et al – presenting as a working group recommendations of clinically 
meaningful outcomes to the United States National Institute on Drug Abuse in 2011 – 
recommended five criteria for treatment outcomes: 
1. the outcome is a consequence or a “strong, concurrent correlate” of a SUD;
2. the outcome is clinically and socially salient and relevant;
3. the outcome is widespread, and not limited to a single substance;
4. the outcome can be assessed via measures that have documented, strong 
psychometric properties; and
5. replicable evidence exists that SUD treatment can alter the outcome. 
Using these criteria, the working group recommended as outcomes of all clinical SUD 
16
treatment trials: changes in quality of life, self-efficacy, craving, psychosocial functioning, 
and social network / social support. 
A review of outcomes reported in SUD treatment follow-up studies in the US in the 
1990s found that 72% of alcohol studies and 82% of drug studies measured at least one non-
substance outcome [44]. At least 40% of alcohol studies measured either emotional, legal, 
vocational, physical health, or additional treatment outcomes. Drug studies were more likely 
to measure non-substance outcomes, but outcomes were more heterogeneous. 38% measured 
mortality, while only one-fifth measured either vocational, physical health, “additional 
treatment”, or social/recreational outcomes. Psychological tests and residential outcomes 
were collected with the least frequency (among 4-7% of studies). This review concludes that 
both types of studies suffer from a lack of uniformity in measuring and reporting outcomes, 
and “a set of standard outcome measures would greatly increase the methodological rigor 
and comparability” of drug studies in particular. 
1.4	  Quality	  of	  life
1.4.1	  Overview
The World Health Organization defines QoL as: 
“Individuals’ perceptions of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns.” It is a broad ranging concept incorporating in a complex way the persons' 
physical health, psychological state, level of independence, social relationships, personal 
beliefs and their relationships to salient features of the environment. [45]
QoL is a holistic (“multidimensional”, in the WHO’s words) measurement that seeks to 
account for the whole person, in accordance with the WHO’s understanding of health as 
more than an absence of illness. 
Importantly, this self-evaluation is embedded within an individual’s cultural context, 
making it more complex than other measurements of “well being” or “life satisfaction”. It is 
relevant to both sick and well people and has been a major outcome in health care since the 
1970s [46]. Moons and others suggest that  the health care focus on QoL among high-income 
countries arose as life expectancy increased, diagnoses of chronic but treatable conditions 
increased, and medical technologies improved, measures beyond mortality  and morbidity 
were developed to evaluate treatment effectiveness [47]. QoL also moves beyond disability 
or functionality  status, perceived health measures, and measures of disease/disabilities’ 
impact on daily life [45]. 
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Higginson and Carr [48] discuss QoL measurements as holding a vital 
communicative role in clinical practice. Patient problems and preferences beyond the disease 
being treated are identified and prioritized by the patient, facilitating communication 
between patient and provider, and providers are able to monitor changes and/or responses to 
treatment. QoL measures can also be used in clinical audits and clinical governance to 
improve treatment quality. 
1.4.2	  Salience	  to	  SUD
By the early 1990s, alcohol studies had regularly assessed QoL as an outcome, but 
drug studies were only beginning to collect QoL (although QoL was assessed by nearly all 
alcohol and drug studies involving dual-diagnosis patients) [40]. 
As reviewed earlier, the addiction field recognizes SUD as a preventable and 
treatable chronic condition [40, 41] that affects a wide range of patient functionings as well 
as physical and psychological health, relationships, and environment. This understanding is 
reflected in the numerous studies that report consistently lower QoL among the SUD 
population compared to the general population [11, 43, 49]; one twin study even held for 
physical and psychiatric comorbidities, combat status, income, marital status [50]. The 
relationship  between SUD and QoL could exist in multiple directions: the detrimental effects 
of a SUD decrease QoL; a SUD develops after self-medicating substance use caused by 
attempts to increase QoL; or SUD patients’ comorbidities or other characteristics that 
develop before, after, or concurrent to a SUD are the main affect on QoL [40]. (That there is 
a definitive association between comorbidities common to SUD patients and low QoL is 
undisputed, but the role of these comorbidities in the development of SUD is undetermined.) 
Laudet points out that the number of substances and severity of SUD are more strongly 
associated with low QoL than the length of SUD, age at onset, prior withdrawal distress, and 
amount of prior treatments, which are all commonly used measures of dependence [51]. The 
complexity of SUD regarding causes/determinants, individual symptoms and effects, and 
social repercussions speaks to the need to address SUD in an appropriately holistic way. 
Poor QoL is both a determinant and outcome of SUD. It can therefore be used in both 
diagnostic and predictive capacities in the context of treatment. Diagnostic in that QoL 
assesses the “lived problems”  of SUD better than measuring SUD severity [40], and by 
requiring/validating patient experiences, captures aspects of disorder and treatment that 
clinicians miss. Laudet also argues that low QoL indicates treatment readiness, as people 
with a SUD attempt to quit or reduce use “not as an end in itself, but as a means to escape 
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these negative consequences and to gain a better life” [51]. These negative consequences 
deserve as much attention in and after treatment as substance consumption itself, and QoL 
measurements allow the patient to appraise her perceived functionings as well as her 
satisfaction with each level of functioning, thereby recognizing the negative, 
multidimensional effects of SUD in a patient’s life [52, 53]. There is also some evidence that 
QoL at treatment completion can predict sustained remission [32, 53], on top of stronger 
evidence that QoL itself increases over the course of treatment [43, 54, 55].
1.4.3	  Measures
The SUD field is slowly  catching up to the rest of the medical field in treating QoL 
as a clinical outcome, but there exists heterogeneity in the different QoL constructs among 
this population. One construct is health-related QoL (HRQoL), an assessment  perceived 
limitations to mental and physical well-being/functioning due to disease [56]. The Short 
Form 36 Health Survey and the 12-item abbreviated version common measurements of 
HRQoL, although some classify these tools as measures of general health status [57].1 
Laudet advocates for a second construct, “generic”  or “overall”  QoL, as the most 
appropriate QoL outcome for the SUD population [51]. Overall QoL encompasses the 
physical and mental domains measured by HRQOL in addition to social relationships, 
religion/belief/spirituality, level of dependence, and living environment, such as housing and 
finances. More than HRQoL, overall QOL attempts to provide an insight into all areas of 
respondents’ lives. Laudet argues that as SUD affects “nearly all areas of functioning,” 
measuring OQOL and its improvements helps “capture the full impact of a medical 
condition and recommended treatment on an individual”  [51]. The WHO’s Quality of Life 
Assessment (100 or 26 items), Quality of Life Scale, and Life Situation Survey are common 
measurements of overall QoL. 
Several substance-specific measures have also been developed, including the 
Injection Drug User QoL Scale [58] and the Health-Related Quality of Life for Drug 
Abusers Test [59]. These measures have only been validated among English, American, 
1 QoL is often used interchangeably with health, and the WHO’s broad definitions of both 
terms perhaps contribute to this conceptual ambiguity. The WHO defines health as “a state of 
complete physical, mental and social well-being and not merely absence of disease or 
infirmity”  - the most noticeable difference between that and QoL is the latter’s requirement 
of self-assessment. Both definitions appear to include each other as determinants or 
indicators, despite multiple meta-analyses’ conclusions that QoL and health are separate 
concepts [see Hubley]. 
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Canadian, and Spanish populations, and as their names suggest, do not measure global QoL 
for all persons with a SUD. 
 QoL may change with statistical significance as a result of an intervention, but it 
cannot be assumed that patients notice that  change or that the change impacts them in any 
meaningful way. The former does not lead to the latter, Jones argues: even if the change is 
noticeable, measuring “just-noticeable change” does not confer meaningfulness [60]. The 
concept of a minimal clinically important difference (MCID) describes a minimum threshold 
of change above which a patient would consider a change in their QoL relevant [61, 62] and 
would consider repeating the intervention again [63]. MCID demonstrates the difference 
between statistical significance and clinical significance [64, 65]. Clinical trials and other 
pre/post studies provide changes in population means, or population-level differences in an 
outcome, and statistical analyses reveal whether the difference can be likely attributed to the 
intervention. “However, patients are not interested in knowing population-level differences. 
Rather, they  wish to know the likelihood that they will experience a meaningful 
improvement for the risk they take with an intervention (ie, ‘Is this change meaningful to 
me?’)” [64]. Clinical significance can occur with or without statistical significance, and can 
be measured by the MCID. 
1.5	  Exercise	  and	  physical	  ac@vity
1.5.1	  As	  public	  health	  prescrip9on
Exercise is largely considered an intentional subset of physical activity, the latter of 
which encompasses any bodily  movement that expends energy [66]. While physical activity 
may be conducted without attention to physical improvement, or as a means to another end – 
such as walking to work or cleaning a floor – exercise is planned, structured, and conducted 
with a goal of maintaining or improving physical fitness. Nevertheless, as the two terms are 
often used as synonyms even within the research community, I review studies using both. 
The WHO identifies physical inactivity as the fourth leading risk factor for global 
mortality [67]. Warburton et  al’s literature review of articles and meta-analyses involving the 
health benefits of physical activity concludes that there exists “irrefutable evidence” that 
physical activity plays an effective role in the primary and secondary prevention of 
premature death and several chronic diseases. The authors proffer a range of biological 
mechanisms that support  this role, such as improved body composition, enhanced lipid 
lipoprotein profiles, reduced blood pressure, reduced systemic inflammation, improved 
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glucose homeostasis and insulin sensitivity, improved autonomic tone, decreased blood 
coagulation, improved coronary blood flow, strengthened cardiac function, and enhanced 
endothelial function. These adaptations, which are not limited to regular physical activity, 
are of global benefit to multiple and individual disease states, specifically, cardiovascular 
disease, some cancers, diabetes mellitus, depression, osteoporosis, obesity, and hypertension 
[68]. Cardiovascular fitness measures improve in a dose-response relationship with physical 
activity [67].
Psychological gains deserve further explanation. Numerous cross-sectional and 
population studies have documented the association between exercise and better “mental 
health” [69, 70], a term that is often a proxy for the combination of depression and anxiety, 
indicative of any  psychiatric diagnosis by the ICD or DSM, representative of mood or well-
being, or reached by  a particular score on a mental or emotional distress scale. Inversely, 
physical inactivity  appears to be a factor in the development of depressive and anxious 
symptoms. 
Depression is currently projected to be the second highest cause of the global illness 
burden by 2020, beyond coronary heart disease, due to the mortality, morbidity, and 
disability  it  causes; it currently causes the largest  amount of non-fatal burden [71]. Exercise 
reduces depressive symptoms among individuals with major depression, as well as among 
well populations and the chronically  ill [69, 72, 73]. Longitudinal studies have also 
confirmed that exercise protects depressive diagnoses after holding for variables such as age, 
sex, socioeconomic status, and health status [74]. One RCT found exercise to be as effective 
as pharmacological treatment in reducing depressive symptoms compared to a placebo [75]. 
Regular exercise also seems to protect against anxiety disorders in large, cross-sectional 
studies [70, 76]. Unlike depression, exercise does not appear to alleviate anxious symptoms 
to the same extent as pharmacological treatment. Exercise is still more effective than no 
treatment, and reduces anxious symptoms among well populations and those diagnosed with 
an anxiety disorder. 
Cotman et al [77] suggest that exercise promotes mental health through directly and 
indirectly improving brain health in protective and therapeutic ways. Exercise directly 
improves cognition, plasticity, neurogenesis, and vascular function through the regulation of 
growth factors [78]. The molecules particularly  explicated in neurogenesis that are affected 
by exercise are serotonin, β-endorphins, brain-derived neurotropic factor (BDNF), and 
vascular endothelial growth factor. (Exercise also reduces peripheral risk factors to the brain, 
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most notably diabetes, hypertension, and cardiovascular disease, through reducing 
inflammation, which is the mechanism by which these disorders interfere with growth 
factor.) Many  neuroadaptations are found in the same areas that undergo critical structural 
change during periods of depression and anxiety [73, 79]. For example, while exercise and 
antidepressants increase hippocampal volume, depression decreases it. Exercise increases 
levels of BDNF in the hippocampus, which decreases anxiety as well as protects against 
depression. 
1.5.2	  Rela9onship	  to	  QoL
In the past decade, exercise has also been explored among healthy and chronic 
disease populations as a way to increase QoL, thanks in part to exercise’s conclusive positive 
health effects, and to the wealth of cross-sectional studies verifying the association between 
a physically active lifestyle and higher QoL [80-86]. Meta-analyses of longitudinal exercise 
interventions among healthy and clinical, non-SUD populations confirm that the physical 
and psychological domains of QoL improve after subjects undergo an exercise intervention 
[46, 87-90]. Sawatzky even suggests that it is exercise that mediates the negative affect of 
chronic conditions on older adults’ QoL [86].
Explorations of a dose-response relationship between exercise and QoL are less 
common [83, 85, 89]. Reviews of cross-sectional and cohort studies, as well as the sparse 
longitudinal studies and RCTs suggest a tenuous dose-response relationship. One of the only 
randomized experiments to measure exercise dose and QoL is Martin et al’s 2008 study [89]. 
The authors found a consistent dose-response relationship, but emphasized that even the 
lowest exercise dose (50% of the American government’s physical activity recommendation, 
or 74 minutes a week), were associated, with statistical significance, with increases in seven 
out of eight measures of previously sedentary participants’ mental and physical QoL. Martin 
et al note, “it is also of interest that physical activity–induced changes in QoL were 
independent of changes in fitness, suggesting that changes in fitness are not required for 
physical activity–induced improvements in QoL”. Gillison et al’s meta-analysis found that a 
dose-response relationship was potentially mediated by health status: well patients and 
patients exercising as a part of a disease management scheme experienced greater QoL gains 
the more they exercised (or the more intense their exercise program), whereas patients 
exercising for rehabilitative purposes benefited more from light over moderate or vigorous 
exercise [46].
The mechanisms by  which exercise positively  affects QoL are unknown. Elavsky’s 
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work among older adults has tested the mediating effects of self-esteem, self-efficacy, and 
positive affect on HRQoL. In one study, the direct effect between physical activity  and 
HRQoL approached significance, but only positive affect was significantly increased by 
physical activity and then significantly increased HRQoL [88]. This finding contradicts 
Rejeski et al’s findings that  self-efficacy was the mediating agent between physical activity 
and HRQoL [52] and Phillips et  al’s findings through their longitudinal study that  “the 
indirect effect of increases in physical activity on increases in QoL was significant only via 
changes in self-efficacy and physical self-worth” [91]. An earlier paper co-authored by 
Elavsky  found physical activity and affect both mediated self-esteem [92]. Among cancer 
patients, a group  of chronically  ill for which exercise is often studied and HRQoL often 
measured, fatigue and stress/distress have been consistently found to be mediators  [93]. It is 
important to note that  most studies examining mediators of QoL have in fact focused only on 
HRQoL, with some suggesting that HRQoL is a subset and influencer of overall QoL [94]. 
Taken together, evidence points to a wealth of psychological outcomes that to various 
degrees mediate exercise’s positive affect on QoL. 
1.5.3	  Salience	  to	  SUD
The American National Institute for Drug Abuse describes eighteen evidence-based 
components of comprehensive SUD treatment, and exercise is conspicuously absent [95]. 
This belies the frequency with which SUD treatment institutions appear to organize 
informal, unmeasured exercise schemes in both Norway and the U.S. Exercise is 
consistently found to have an inverse relationship with SUD, yet the causality in this 
relationship  has been explored primarily on the preclinical level [96]. There are three 
possible causal relationships: first, an external factor could lead to lower exercise and higher 
substance rates, such as an element of the home environment, personality  trait, or 
comorbidity. Second, substance use could causally decrease exercise, due to the time and 
resources substance use requires and/or to the adverse aerobic effect substance use has on 
users. Third, exercise could causally reduce substance use.  
Preclinical evidence suggests that exercise bears striking similarities in neurological 
and behavioral consequences to substance use [96-101]. Both substances and exercise are 
positive reinforcers among humans and animals, activating the reward pathway through 
increases in dopamine concentrations and in dopamine receptor-binding. Additionally, 
exercise normalizes the signaling of other neurotransmitters pertinent to SUD (e.g. 
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norepinephrine and glutamate), and blocks and reverses some neuroadaptations in the 
mesolimbic region that develop in the maintenance of SUD, such as by dampening higher-
receptivity among the opioid receptor system. Regarding SUD’s inhibitory effect on the 
executive system (see 1.3.4 Etiology), exercise enhances the abilities of the hippocampus 
and prefrontal cortex to resist compulsive patterns of substance use via neurogenesis and 
gliogenesis. Among animal studies examining all phases of substance abuse – acquisition, 
maintenance, escalation, binge/compulsive use, and relapse/reinstatement – voluntary and 
involuntary exercise reduces the self-administration of cocaine, stimulants and opioids. 
(Fewer preclinical studies have reported on alcohol, and the evidence is mixed.) Human 
studies show the same results for nicotine and cannabis [102, 103].
Behaviorally, exercise reduces the relative reinforcing strength of substances and 
serves as an alternative, non-substance reinforcer to substance self-administration [96]. 
Exercise reduces negative affective states that have been identified as “initiating, 
maintaining, and accelerating” SUD [96]; for example, exercise decreases comorbid risk 
factors that lead to substance craving and relapse, such as depression, anxiety, and reactivity 
to stress [100]. Exercising subjects also consume fewer substances as a way of coping with 
stress. Exercise promotes positive effective states that are associated with low SUD and 
possibly protect against SUD, including QoL, as discussed above, self-efficacy, and self-
esteem [104]. Exercise can also serve as a positive, non-substance activity, which patients 
recovering from SUD are in sore need of [105]
Finnish longitudinal twin data shows the protective effect of adolescent exercise 
against substance use in young adulthood, even when holding for familial factors [50]. 
Exercise has accordingly been used as a preventative measure, particularly among youth and 
other at-risk groups [106, 107]. Exercise has been introduced both adjunctly to and after 
treatment in order to decrease substance use, support abstinence, and improve substance use 
outcomes. Several studies suggest that physically  active patients are significantly less likely 
to relapse than those who are sedentary [1, 105, 106, 108], while randomized control trials 
provide convincing evidence among the nicotine-abusing population [102, 104]. 
Exercise in the treatment setting often has additional goals. Most directly, exercise is 
used as a remedy for patients’ typically dismal physical conditions, particularly 
cardiovascular health [105, 109], although numerous other chronic disease sufferers can 
enjoy  definitive health improvements [46]. Symptom management or reduction is often a 
specific goal, and reductions or improvements in psychiatric comorbidities can be included 
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here. Exercise-induced improvements in psychological outcomes within mood management, 
anxiety and depression, and improved resilience factors such as self-confidence have also 
been identified as factors leading to high SUD treatment adherence [109]. 
While attrition rates in exercise programs are no better than overall SUD treatment 
attrition rates, patients seem to be positive to the opportunity of group exercise. Recent 
Norwegian data confirms that  SUD inpatients report a significant drop in activities, 
including physical activities, after the onset of a SUD, and that this drop is negatively 
associated with their reported well-being. Physical activity was the most commonly reported 
lost activity  and the most commonly desired activity [110]. In the U.S., Read et al found that 
75% of outpatients of an intensive alcohol treatment program expressed interest in an 
exercise scheme tailored to those with a SUD, with two-thirds selecting both walking and 
strength-training as activities they would enjoy [111]. Similarly, 95% of another substance 
abuse outpatient program reported interested in exercise targeted to them, and 75% identified 
walking as one preference and another 37% identified strength-training [112] . While those 
in treatment or recovering from a SUD are typically of markedly poorer physical condition 
than the general population, only  three percent of participants Read et al’s study reported 
that their “poor physical condition” would be a barrier to exercise. 
1.5.4	  Best	  prac9ces	  from	  exercise	  interven9ons
There is a wealth of literature published on determinants of adherence to exercise 
interventions, but far fewer analyses of adherence- and acceptability-maximizing factors of 
such interventions exist. Most literature reviewed applies to interventions engaging healthy 
or chronically ill populations, and the handful that involves SUD patients will be 
highlighted. 
Group  exercise appears to be more beneficial than individual exercise. Two meta-
analyses have concluded that adherence to group- and facility-based interventions is higher 
than adherence to individual- and home-based programs [113, 114], possibly due to a 
consistent schedule and peer accountability [115]. If exercising in a group encourages 
adherence, then participants receive higher doses and longer durations of treatment, a 
hypothesis that seems to be confirmed by another meta-analysis of exercise interventions’ 
effect on QoL that finds improved QoL among healthy and clinical populations that 
exercised in groups but not among those with home-based or individual regimens [46]. 
Home-based training has the further drawback of being unsupervised, and adult  participants 
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have been found to consistently over-report the length and intensity of physical activity 
conducted individually [116].
The socialness of group exercise may add to positive neurochemical benefits. 
University  of Oxford researchers recently found that pain tolerance, a noninvasive measure 
of endorphin production, was twice as high among subjects who performed an exercise 
session in a group compared to subjects who completed the same session alone [117]. While 
their sample was small, they suggest that physical group  activities stimulate endorphin 
production, and that this endorphin release plays a role in social bonding as well as having a 
documented analgesic effect. 
A meta-analysis of 11 RCTs using financial incentives as part of exercise 
interventions concluded that incentives improve exercise adherence in the short-term (less 
than 6 months) [118]. 
Perhaps the best design suggestions for this pilot study are surveys of exercise 
preferences among SUD patients. In these surveys, sedentary SUD patients identify nearly 
identical barriers to exercise as healthy populations: high perceived costs of equipment and 
facilities, low motivation, lack of transportation, lack of time, and low perceived social 
support [111, 112, 119]. The attributes of an exercise program may also prove problematic 
for some participants. For example, despite some evidence for a dose-response relationship 
between amount of exercise and QoL benefits, small studies such as this must also balance 
the potential decrease in adherence that accompanies increased intensity  [120] and dose 
[113]. 
2.	  Methods
2.1	  Theore@cal	  assump@on
 I am approaching this project as a post-positivist. The vast majority  of SUD and 
evidence-based research in general is constructed with an evidently positivist 
epistemological commitment: substance use, misuse, and abuse are evident and measureable 
by researchers through the diagnostic tools of the DSM  or ICD, levels of exercise are 
similarly  quantifiable, and so on. To a large extent, I am not questioning the truthfulness of 
such measurements. 
My hypothesis, that exercising participants will have experienced changes to the 
physical health and social relationships domains of their QoL over the course of this 
intervention, includes multiple post-positivist assumptions that must be acknowledged. First, 
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that the changes they  experience are positive, that is, that participants themselves observe 
changes and will report  them, given the correct reporting tools and asked the “correct” 
questions. At the same time, while I will defend my selected QoL tool as globally  validated 
and cross-culturally sensitive in 2.6 Measures, it  cannot possibly  be purported to be an 
exhaustive measure. In Schwandt’s words, “the language of science is irreducibly 
metaphorical and inexact,” and thus cannot be expected to capture the inexactness of reality 
itself [121].
A second hallmark of post-positivism is the acknowledgement that “science consists 
of research projects or programs structured by presuppositions about the nature of 
reality” [121]. The researcher must be reflexive as to her impact on the design, 
implementation, and analysis of a project. I am keenly aware that my career in homelessness 
policy, wherein there exists some overlap with the field of addiction, my personal 
background as an athlete, and my experience with a running club for a similarly 
disadvantage group  have, among others, shaped this study design and expectations. I chose 
primarily  quantitative methods with validated measures in an attempt to exclude my 
presuppositions as much as possible. This is not to say, however, that quantitative methods 
bring me closer to an objective researcher ideal: “All our observing is done within a horizon 
of expectations and is therefore necessarily selective” [122]. 
The choice to make the bulk of analysis in this pilot study quantitative was also 
prompted by  my  intention to optimize cross-cultural transferability of knowledge, that is, to 
make even a modest claim of generalizability from Norway to for example the United States. 
I approached this study design with a goal of producing knowledge that would be useful also 
outside of the Norwegian context, and in order to limit  the translation and re-translation of 
qualitative data and analysis, (ostensibly) supra-linguistic quantitative data seemed most 
desirable. That my interpretations and translations of qualitative information could be error-
full is a particularly salient concern, given that I conducted this pilot study in a language and 
country  that I had learned and lived in for less than one year. Relying on my ability to 
construct a narrative with participants by “disrupt[ing] the predictability that can occur in 
traditional interviews” would be to dangerously ignore the linguistic and cultural barriers 
between us, that is, the existence of discourse [123].
The subjectivity  of the quantitative data I collected is also of methodological 
significance. The choice to collect  QoL assessments privileges the knowledge of the 
participants themselves. I worked with a group  of individuals that includes those engaging in 
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extralegal activities (i.e. illicit substance use), deprived in most countries of the right  to 
treatment and health care for such behavior, and mistrusted as an aggregate and as 
individuals. Their opinions are mistrusted for falseness, their motives are mistrusted for 
taints of addiction, their behaviors are mistrusted as symptoms, and their judgment is 
mistrusted as skewed. I trusted them with the ability  to judge the quality of their own lives, 
and I did not verify these assessments against medical professionals’ evaluations or adjunct 
measures of quality, such as decreased substance use. I have collected adjunct medical data, 
but this is to provide a fuller picture of the sample’s characteristics and the changes they 
experienced throughout  the study, and not to strengthen or prove findings about participants’ 
own judgment of their quality of life. 
In some ways, this choice could be viewed as an attempt to empower marginalized 
perspectives and their “distinctive, and discrepant, epistemological frameworks” [124], and 
indeed, I hope that participants will appreciate my technique of relying on their own 
knowledge. But any empowerment ends at this knowledge source – ultimately, I am treating 
participants as knowledge sources, not knowledge makers, thus excluding myself from a 
constructionist paradigm. Hammersley would see this methodology as an attempt to avoid 
creating etic-centric theory, a technique often employed by  post-positivists as a response to 
intra-paradigmatic criticisms [124]. It is for this reason that I identify them as participants 
and not subjects. I am not asking participants for their own interpretations, or for knowledge 
in their own words. I am giving them questionnaires to indicate their agreement or 
disagreement with. (These questionnaires could perpetuate inequalities based on gender, 
race, socioeconomic status, SUD state, and others. A full analysis of such potential 
inequalities is not within the scope of this project, yet addressing their potentiality is 
required.) I will judge the quality of my project by “conventional benchmarks of ‘rigor’”, 
namely internal validity, external validity, and reliability [125].
The qualitative data collected is limited to that needed for a low-level process 
evaluation: what worked, what  did not work, and whether the overall experience was 
positive or negative. A content analysis is performed on spontaneous and structured feedback 
participants during and after our sessions, in order to learn more about feasibility  of the 
intervention.
28
2.2	  SeBng
The pilot study ran between August and November 2013. Study  sites in Oslo were 
included after outreach from October 2012 to July  2013. Each site was an intensive 
residential program that treated patients with a SUD in the post-acute/post-detoxification 
phase. All four sites provided housing and supportive services such as on-site psychologists, 
psychiatrists, group therapy, group activities and outings, and some meals, as well as 
linkages to occupational training and continuing education. The table below shows the 
characteristics of the participating four institutions.
Table 2.1 Participating site characteristics
Public/ 
private
No. of 
residents
Opioid 
replacement 
therapy
Residents’ SUD 
profile
Expected 
length of stay
Site 1 Private 28 No Mix 1-2 years
Site 2 Public 18 Yes Mix 1-2 years
Site 3 Public 23 No Mix 1-2 years
Site 4 Public 33 No Alcohol > 2 years
I and the second coach met with each group  of participants at their institutions. The majority 
of sessions utilized on-site facilities, such as weight-lifting equipment, and freely accessible 
outdoor facilities within one kilometer, such as local parks, running paths, and sand 
volleyball courts.  
2.3	  Sample
Participants were recruited during 30-minute presentations in each institution. In 
institutions 1 and 2, I recruited only  among a group that was already interested, while in 
institutions 3 and 4, I recruited among a majority  of residents during mandatory  resident 
meetings. 50 individuals were recruited, of which 35 enrolled and provided baseline data, 
and 31 provided data at the study’s end.  
Inclusion and exclusion criteria. Inclusion criteria, as measured on the screening 
tool, included: a) between the ages of 18-65; b) self-identification as sedentary, i.e. having 
not exercised for more than 20 minutes a day, three days a week, for the past six months; c) a 
recent history  of a SUD, as demonstrated by participants’ residence in the institutions; and d) 
ability  to give informed consent. The only exclusion criterion was self-reported pregnancy or 
intent to become pregnant in the next ten weeks. 
Comparison group. A comparison group was supposed to be established to attempt to 
exclude any effect arising from the non-intervention treatment itself during the 10 week 
exercise program. The comparison was intended to be comprised of patients and residents at 
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each site who completed the screening tools and answered the QoL instrument both before 
and after the pilot study but chose not to participate in the exercise groups. Only three 
residents out of a goal of 30 were recruited into the comparison group. Instead of 
abandoning the data from these three residents, I have added them to the eight who enrolled 
in the exercise group but never attended a session, and I have analyzed this group of eleven 
as “non-exercisers”. Non-exercisers received the same incentives at start-up, answered the 
same tools at baseline and follow-up, and took part in the follow-up data collection dinners. 
See 2.7 Analysis for further discussion. 
2.3.1	  Ethics	  and	  consent
The study protocols and procedures were approved by the Norwegian Regional 
Committee for Medical and Health Research Ethics. Institutions were supplied upon request 
with the study design and questionnaires before recruiting residents. 
Study participation did not interfere with or eclipse institution-provided services. The 
main points of the consent forms were repeated verbally to all residents during recruitment, 
namely: 1) withdrawal was possible at any point  in the study; 2) injuries were possible, 
although unlikely; 3) muscular soreness was likely, although not dangerous; and 4) the data 
provided by  participants would not be made available to their institutions, and would be 
anonymous during data analysis and in the final report. 
2.4	  Hypothesis
The only hypothesis tested in this pilot study is related to the second research aim, 
which is to determine if the exercise intervention had an effect on QoL: 
H0: QoL does not change after participation in an exercise intervention.  
H1: QoL changes after participation in an exercise intervention. 
2.5	  Interven@on
2.5.1	  Type
The pilot study engaged participants in each institution in aerobic exercise and 
strength-training sessions as a group, led by  myself (institutions 1-3) and a trained, hired 
coach (institution 4) who I supervised for one-third of the program. Each institution began 
with a loose schedule that  assigned, for example, ball sports on Mondays, running on 
Tuesdays, and circuit workouts on Thursdays. The social aspect of the intervention was 
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highlighted through the tagline of the program, “a social, laid-back exercise club for those 
with a substance use history” [en sosial, lavintensiv treningsklubb for de med rusbakgrunn], 
and each session’s structure. Sessions began with the coaches thanking participants for 
coming and saying, “All of us are strong, and we can only  get stronger” [Vi er allerede 
sterke, og kan bare bli enda sterkere]. 
2.5.2	  Dura9on,	  dose	  and	  frequency
Each intervention site provided participants with ten weeks of low-intensity aerobic 
exercise, a duration attained by averaging the duration of 32 studies in Zschucke et al’s 
meta-analysis investigating the relapse effects of exercise interventions among subjects in 
treatment for nicotine, alcohol, or illicit substance abuse and dependence [126]. 
A variety of methods exist  that could have been used to ensure participants exerted 
themselves to a specific degree, such as self-measured heart  rates or Perceived Rates of 
Exertion [127]. However, these were abandoned in fear that prescribing a particular amount 
of exertion would deter participants who self-reported as sedentary and as having a large 
number of health problems. The focus was instead on completing the activity itself within 30 
minutes – e.g. three sets of sand volleyball, one 3.2-kilometer lap around a lake, abdominal 
exercises to music – and participants were encouraged to push themselves, but also allowed 
to rest or stop at  their discretion. 30 minutes was rounded down from 36 minutes, an average 
of Zschucke et al’s 32 studies. A three sessions/week prescription is again based on an 
average of studies’ frequencies (3.45) reviewed by Zschucke et al [126] .
2.5.3	  Safety
I and the coach were certified in basic First Aid. I carried a small amount of bandages 
with me to each session, while institution 4 kept full First Aid kits on-site, where all of the 
sessions were held. With one exception – one institution’s weekly runs around a lake that 
required a subway  trip – all sessions were held either on-site or in the very  near vicinity  of 
the institutions, and any safety concerns could be immediately relayed to institution staff. 
2.5.4	  Volunteers	  and	  other	  par9cipants
The original goal of a one-to-one volunteer-to-participant ratio, for the sake of 
creating a club environment and maximizing social support of participants, was not 
achieved. Instead, institution 1 had two volunteers – one staff member and one former staff 
member – who attended one or two sessions per week, institution 3 had four volunteers, and 
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institution 4 had one staff member who regularly attended one session per week. In addition, 
three non-enrolled residents from institutions 1 and 3 regularly attended sessions; they 
signed the consent form but did not provide any baseline or follow-data. 
2.5.5	  Adherence	  strategies
Table 2.2 Adherence strategies
• Group setting • No costs to participants
• Supervised/coach-led sessions • Low dose and intensity of exercise
• Positive adherence feedback from coach • Schedule set by participants
• Coach independent from SUD treatment 
institution
• No travel required; coaches met participants 
at institutions
• Incentives • Variation in activities
• Training reminders via SMS • Activities selected with participant input
Neither coach was trained in motivational techniques, so the strategies used to 
increase motivation were rudimentary at best. A high amount of coach-to-participant 
communication was one important strategy. In addition to SMS reminders of sessions and 
upcoming incentives, coaches provided activity  and adherence feedback in person and 
through SMSes. Groups received a common SMS every  three weeks that summed up the 
minutes of activity, number of push-ups, kilometers walked, etc., that each group had 
collectively accomplished, and individuals were either told in person or received 
personalized SMSes describing particular exercise milestones. 
Participants who expressed uncertainty about their participation in an upcoming 
session received a response from a coach that emphasized that participation was voluntary 
and the group was meant to be for the benefit and enjoyment of the participant, and added 
either a) the sessions were more fun when those participants were present, or b) the coaches 
would simply be happy to see them next time. 
Incentives were used to stimulate enrollment and attendance. They took the form of 
small exercise-related prizes (e.g. water bottles, running gloves), supplemental activities near 
the end of the program (e.g. a kickboxing class, laser tag), personal training sessions, and 
one-month memberships to fitness centers. Incentives were procured through local training 
centers (Elixia Ullevaal, Mudo Kampsport), a sports organization (Kondis), running race 
(Sognsvann Rundt Medsols), and a physiotherapy  center (NEMUS Bryn). To proactively 
motivate participants to participate and compensate for the potential lack of enjoyability 
accompanying a new exercise regime, incentives were given to all participants at weeks 1 
and 3. To emphasize participants’ successes, such as the highest participation rate or the most 
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kilometers run/walked,  and to assign value to those successes supplementary to the value 
that participants may have already assigned, further incentives were provided at weeks 7 and 
9. All participants, including non-exercisers, received the last batch of incentives as 
completion prizes at follow-up. 
2.6	  Measures	  
2.6.1	  World	  Health	  Organiza9on’s	  Quality	  of	  Life	  Brief	  (WHOQOL-­‐BREF)
The WHOQOL-BREF is a self-administered, abbreviated version of the World 
Health Organization’s 100-item Quality  of Life assessment (WHOQOL-100). The 
instrument measures overall quality of life in the first item and overall health in the second 
item, and the remaining 24 items are divided into four domains: physical health (seven 
items), psychological health (six items), social relationships (three items), and environment 
(eight items). Response categories are rated on a 1-5 Likert scale, in which higher scores 
indicate higher QoL. Up to one missing item in the physical health and environment 
domains can be replaced with the domain mean. Domain means are then translated into 
domain scores comparable to the larger WHOQOL-100, via formula provided by the WHO 
[128]. 
The WHOQOL-BREF has been validated across 15 sites internationally, in 19 
languages [128, 129], and among the SUD population [130, 131]. It has shown satisfactory 
psychometric values in Norwegian population studies [132, 133]. The original WHOQOL-
BREF produced a Cronbach’s alpha coefficient of 0.80 in the physical health domain, 0.76 in 
psychological health, 0.66 in social relationships, and 0.80 in environment [134], while the 
Norwegian version has produced a Cronbach’s alpha of 0.84 in physical health, 0.82 in 
psychological health, 0.60 and social relationships, and 0.79 in environment [132]. 
Completion requires between ten and fifteen minutes.
2.6.2	  Norwegian	  Follow-­‐up	  Study	  of	  Opioid-­‐dependents	  in	  Treatment
The screening tool included excerpts from the Norwegian Follow-up Study  of 
Opioid-Dependents in Treatment (Norsk oppfølgingsstudie av opioid-avhengige i 
behandling, or “NorComt”), developed by  the Norwegian Center for Addiction Research. It 
collected demographic, somatic and psychological health data through the inclusion of the 
25-question Hopkins Symptoms Checklist (see below), SUD profile, and SUD treatment 
history. Substance use at  baseline was measured by asking for all use over the past six 
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months, while substance use at follow-up asked only  for use since the intervention began, 
approximately two months. Participants selected from a comprehensive list of 19 substances, 
including an “other” option. Somatic health burden was measured by  the amount of somatic 
conditions participants reported suffering from, out of a list of 25. This tool required 
approximately 40 minutes to complete. 
2.6.3	  Hopkins	  Symptoms	  Checklist
The 25-question Hopkins Symptoms Checklist (SCL-25 or HSCL-25) is a widely 
used screening tool for emotional distress, and includes two subscales for anxiety  (10 items) 
and depression (15 items). The HSCL-25 has been translated into at least 15 languages and 
is used in both population studies and among clinical or traumatized respondents, such as 
refugees and asylum seekers, torture victims, and victims of assault [135-140]. Norwegian 
and Swedish researchers in particular have validated it through several longitudinal studies 
[136, 141]. 
An emotional distress score is achieved through a simple mean of all items, and 
likewise for the anxiety and depression scales. Missing item scores were replaced by the 
overall mean score, if two or less item scores were missing.  A high score (≥1.75 when using 
a 1-4 Likert scale, and ≥1.0 when using a 0-4 Likert scale) has been shown to correlate with 
severe emotional distress [142, 143], and the depression subscale score correlates with the 
DSVM-IV’s measurement of major depression [137]. The HSCL-25’s utility in this 
intervention is suggested by  its high internal reliability, cross-cultural validity, broad use 
among traumatized populations and populations being screened for psychiatric disorders, 
and the short amount of time required to complete it. The HSCL-25 and its variants, the 
HSCL-10 and HSCL-90, are used with regularity  among the SUD population in Norway [12, 
144, 145], which will enable comparison with this study’s results. 
2.6.4	  Interven9on	  feasibility
Much of the data for this pilot study was collected to inform the design of a larger-
scale study. The experiences of participants themselves were probed to ascertain intervention 
acceptability. Individual feedback was collected during and after each training session in an 
impromptu manner: I and the coach asked participants how easy/difficult it was for them to 
come to a session, if they liked that session and would like to repeat it, if they were seeing 
any results, and so on. Such feedback was used to make minor adjustments as needed, such 
as the time of day of sessions. 
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The intervention’s study  protocol originally called for a participant-by-participant 
exploration of reasons for non-attendance; the coaches intended on asking each participant 
who had missed a previous session for their reasons. This plan was soon abandoned after 
multiple participants reacted negatively to these questions, citing the voluntariness of the 
program and not wanting to feel guilty. After three participants mentioned that their “bad 
conscience” at missing a session led to further non-attendance, the coaches ceased asking for 
reasons for missed sessions. Coaches continued to send each participant, including non-
exercisers enrolled in the exercise group, reminder SMSes, and after one missed session, 
added that the participant’s presence was missed, with a positive emoticon. These SMSes 
often prompted a response, either through SMS or in person, during the next session, and 
some participants met with coaches before sessions to explain why they  were not attending 
that day. This spontaneous feedback was recorded.  
	
 Each site provided follow-up data during the final celebration dinner. Participants 
were told that they could either give feedback orally or via the follow-up instrument, and 
were then asked for their recommendations for improvement (what did not work), the 
aspects of the intervention that they liked (what worked), and a description of their overall 
experience.  
2.6.5	  Assessment	  schedule
Participants completed the screening tool, WHOQOL-BREF, and consent forms 
before the intervention began. Coaches, participants, and comparison group members met 
again after ten weeks’ of training to celebrate the program end with a group dinner. I 
distributed completion prizes, announced winners of a monthly  membership  to a training 
center, gave each participant a written record of the amount of training s/he had completed, 
and spoke briefly about how participants could maintain an exercise regimen in the future. 
Participants then completed the WHOQOL-BREF a second time as well as a follow-up 
instrument, which included recent substance use, somatic and psychological health data 
excerpts from the screening tool. 
All instruments were completed with pen and paper by participants, with myself and 
in some cases a staff member present. In order to prevent the artificial under-reporting of 
distress and other sensitive problems that Sandager et al witnessed when their Norwegian 
subjects answered the HSCL-25 orally instead of privately [146], participants were assured 
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that their individual answers would remain anonymous from the coaches and especially from 
institution staff.  
2.7	  Analysis
Participants who attended at least one session were analyzed as exercisers. 
Participants who enrolled in the exercise group but who did not attend any  sessions were 
analyzed along with the comparison group members as non-exercisers. As one of the aims of 
this study is to explore whom the exercise group appealed to based on demographic, clinical, 
and QoL variables at  baseline, the group of non-exercisers shares the important characteristic 
of never being interested enough in the exercise group to attend. 
2.7.1	  Quan9ta9ve	  analysis
The first  aim in this pilot  study was to describe this sample of SUD patients and 
discover whom the exercise groups appealed to based on the characteristics of those who 
exercised and those who did not. SPSS for Mac, version 21, was used for analysis. Because 
this pilot study  involved a relatively small sample size (n=35), measurements could not be 
expected to follow a normal distribution. The study  design includes an intervention group 
and a comparison group recruited from the same institutions. The participants in both groups 
self-selected, and no random assignment was performed. This may introduce the potential 
for selection/participant bias. The non-parametric equivalent  of an independent t-test, Mann-
Whitney U tests, were therefore used to compare exercisers’ and non-exercisers’ means in 
each QoL domain as well as major clinical variables of somatic health burden, mental health 
burden, and addiction severity  at baseline. Only the significance values from these tests are 
included in the Results. Sections 3.2 Research Aim 2: QoL changes and 3.3.1 Changes in 
clinical variables present descriptive and statistical comparison of baseline means of QoL 
and clinical variables. Results are often presented with percentages in addition to amounts of 
participants (although a low n), as the unequal group sizes can make comparing n’s difficult. 
The second aim, and that for which a hypothesis is tested, involved measuring QoL 
changes in participants. All participants were currently undergoing residential SUD 
treatment, and QoL benefits can be expected as a result of treatment [147-150]. The question 
to answer, then, is if exercisers’ QoL changed in a different manner than non-exercisers after 
ten weeks – if so, conscious of the methodological limits of this pilot study, additional 
changes can be suggested as arising from the exercise program. For descriptive statistics, 
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exercisers were divided into three roughly  even categories of attendance (“most active”, 
between 20-29 sessions; “moderately active”, between 11-20 session; and “least active”, 
between 1-10 sessions) and their QoL changes compared to expose a potential dose-response 
relationship. 
An appropriate and precise statistical technique to measure changes in QoL between 
the two groups is a general linear model (GLM) with repeated measures. This procedure uses 
analysis of variance to model a dependent variable. It is utilized specifically when the 
dependent variable is measured among the same subjects are at two or more points in time, 
and when subjects are exposed to a single independent variable, such as a treatment [151]. 
The robustness of repeated measure designs is that they  measure between-group variance 
while allowing the subjects to serve as their own control (accounting for within-group 
variance), so significant, observed changes in the dependent variable between groups are not 
attributable to normal variation between participant’s first and second measurements. 
The GLM  with repeated measures helps answer the second research aim in two steps. 
The first step is measuring within-group variance, or how exercisers’ QoL changed over time 
and how non-exercisers’ QoL change over time. Time is therefore the within-group factor in 
this study, as it signifies multiple measurements (baseline and follow-up) of each of the four 
dependent variables of QoL domain. A significant effect of the variable time indicates that 
all participants’ follow-up scores in a domain were significantly different from their baseline 
scores; i.e. a particular domain of QoL changed positively or negatively over the course (that 
is, time) of the pilot study. Given existing research about the QoL-boosting effects of SUD 
treatment, it would be unsurprising if each domain had a significant effect of time.
The four plots below are sample output plots from a GLM with repeated measures 
[152]. Similar output plot will be presented and interpreted in the Results section. Here, the 
y-axis represents measurement of the dependent variable, and the x-axis shows that the 
dependent variable was measured at three points in time. Each line represents a different 
group. Slopes that are either both positive (sample plot 2) or both negative (sample plot 1), 
even if unequally so, reflect a significant effect of time, because all participants’ dependent 
variables changed significantly over time. Slopes that are near zero, indicating no change in 
the dependent variable (sample plot 3) reflect an insignificant effect of time. Slopes that 
are both positive and negative, indicating changes in different directions (sample plot 4), also 
show insignificant effect of time, because if change for this entire cohort (i.e. both groups) 
were to be measured, there would be no net change and we would see a slope of near zero. 
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In effect, this part of the analysis will answer if QoL changed during the 10 weeks of 
observation (over time) while participants were in SUD treatment, comparing QoL scores 
from baseline with QoL scores at follow-up.
Sample plot 1 Sample plot 2
Sample plot 3 Sample plot 4
The second step is to measure QoL changes with attention to the between-group 
factor of exercise. This is the main independent variable, and delineates the treatment 
(exercisers) from the control/comparison (non-exercisers).  A significant effect of an 
interaction between time and exercise indicates that a QoL domain change was 
different for the exercise and non-exercise groups. Such a domain change is reflected by the 
two lines in the above plots having different slopes, as seen in sample plots 1 and 4. 
The model for each domain met the following assumptions: domain scores were 
normally distributed; independence of observations; homogeneity of variance; and 
homogeneity of intercorrelations. Mauchly’s test of sphericity was violated in each, so the 
Greenhouse-Geisser F-tests were used. Plots of each model supplement the results and 
indicate the direction of QoL changes. 
To assess whether any statistically significant changes attributable to exercise were 
meaningful, the minimum clinically important difference (MCID) was calculated. I applied 
the distribution-based method utilized by Den Oudsten et al in their estimation of the MCID 
of the WHOQOL-100 [61]. They calculated the MCID to be 0.5 of the standard deviation of 
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each domain score; a mean change above the MCID can be considered clinically significant. 
There are several other possible distribution- and anchor-based methods [60, 62, 64], but 
Yost recommends this method as the most appropriate when an instrument-specific MCID is 
lacking [153, 154], and Norman et al’s systematic review concludes that 0.5 of the standard 
deviation of change has a “remarkable universality”  when used to discriminate HRQOL 
changes among chronic disease populations [155]. To my knowledge, this is the first study 
proposing MCID values for the WHOQOL-BREF. 
The third aim of this study is to consider additional explanatory factors that may have 
influenced QoL changes. Adding baseline measurements of somatic health burden, mental 
health burden, and recent substance use as covariates to the GLM would have allowed for a 
test of the effect  of exercise on QoL, controlling for the variation in covariate levels. Each of 
these variables have established relationships to QoL [11, 43, 49, 156, 157]. Covariates are 
particularly pertinent in non-experimental situations such as this pilot study, where subjects 
are not randomly  assigned, and hence selection/participation bias may  have influenced the 
results. However, with both positive and negative implications, each clinical variable 
violated a requisite assumption and therefore none could be added to the model. 1) 
Substance use was skewed towards abstinence and not normally  distributed, although 
exercisers and non-exercisers’ substance use were not statistically different. 2) Mental health 
burden at  baseline was linearly related to only the first  three QoL domains – the greater 
burden one had, the worse evaluation of physical health QoL, psychological health QoL, and 
social relationships QoL – and exercisers reported a higher mental health burden, with 
statistical significance, than non-exercisers. 3) Somatic health burden was also statistically 
higher for exercisers than non-exercisers. It  was also linearly related to only  the first QoL 
three domains; the more somatic problems a participant had, the lower they rated their 
physical health QoL, psychological health QoL, and social relationships QoL.  In ay  case, 
the low n in this pilot would have only  allowed for the inclusion of one or two covariates, if 
requisite assumptions of the model were not violated, whereas a larger study  could 
potentially have included several covariates.  
That these clinical variables cannot be added to the statistical models requires 
consideration of their potential influence on QoL to instead utilize descriptive statistics and 
existing research. 3.3.1 Changes in clinical variables presents these descriptive statistics. 
In a study with a larger n it would likely have been less problematic to include these 
covariates into the model, as larger samples often tend to show normal distribution 
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properties, and hence do not violate model prerequisites, as was the case in this small pilot 
study. Including covariates would have been the next analytic step to dissect the potential 
effect of exercise on each QoL domain, and will be an appropriate measure in a future large-
scale trial.
2.7.2	  Qualita9ve	  feedback
To evaluate program feasibility for institutions and program acceptability by 
participants, a content analysis was conducted on spontaneous qualitative feedback collected 
during the program and with structured qualitative feedback collected at program end, and 
integrated with attendance data relating to particular activities. Content analysis identified 
the existence and frequency of themes relating to benefits, challenges, and 
recommendations. 
2.7.3	  Missing	  data
Three participants at baseline declined to answer most of the clinical questions, but 
answered the full QoL instrument. Four different participants could not be reached to answer 
the follow-up instruments. One of these was an exerciser, and the other three were non-
exercisers. 
3.	  Results
3.1	  Research	  Aim	  1:	  Sample	  descrip@on
3.1.1	  Demographic	  and	  clinical	  variables2	  at	  baseline
Participants’ ages ranged from 27 to 61 with a mean age of 41 and standard deviation 
of 8. Three-fourths of participants (74%) were male. Most participants were of Norwegian or 
Nordic descent (94%). The majority (62%) had never married. The largest group of 
participants (43%) responded that they were both outside of the labor market and not 
studying, although exercisers were four times more likely  than non-exercisers to be in this 
position. Slightly fewer (34%) were students, and less than 12% were employed either full- 
or part-time. Nearly 80% of participants had completed secondary education/training or less. 
2 For many demographic questions, at least one exerciser and one non-exerciser declined to answer; 
the percentages presented are of the participants who gave data.
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17% had formal occupational training, above the secondary school level, and only one 
participant completed higher education. 
Table 3.1 Sample description
Total Exercisers Non-exercisers
Age 1972.5 
(SD=8)
1973 
(SD=8)
1972 
(SD=10)
Gender n=35 n=24 n=11
Female 9 8 1
Male 26 16 10
Education level n=33 n=23 n=10
Primary school 11 7 4
Secondary school or occupational 
training
15 11 4
Trade school 6 4 2
University/university college 1 1 0
Above university 0 0 0
Did not complete primary school 0 0 0
Occupation n=34 n=24 n=10
Neither employed nor a student 15 12 3
Student 12 7 5
Part-time work 2 2 0
Full-time work 2 1 1
Unknown 3 2 1
Civil status n=32 n=22 n=10
Not provided 4 3 1
Never married 22 14 8
Widowed 0 0 0
Married 0 0 0
Separated from spouse/ cohabitant 3 2 1
Divorced 3 3 0
Most common somatic conditions n=33 n=23 n=10
Impaired memory 22 17 5
Headaches 18 15 3
Tooth/gum problems 17 13 4
Dizziness 15 13 2
Constipation 15 15 0
Joint pain 14 14 1
Respiratory problems 10 10 0
Psychological conditions n=33 n=23 n=10
Clinical emotional distress 18 17 1
Clinical depression 18 17 1
Clinical anxiety 16 13 3
Depression, lifetime 23 18 5
Anxiety, lifetime 21 15 6
Prescribed medicine for an emotional/ 
psychological problem, recent
11 10 1
Prescribed medicine for an emotional/ 
psychological problem, lifetime
17 13 4
Serious suicidal thoughts, recent 4 4 0
Serious suicidal thoughts, lifetime 16 12 4
41
The average participant suffered from 20 out of 25 somatic conditions, and there 
were no participants who did not suffer from at least one condition. Exercisers suffered 
significantly (p=0.004) more from somatic conditions than non-exercisers. 
A majority of participants reported clinical emotional distress, as measured by the 
HSCL-25. 18 reported clinical depression, and 16 reported clinical anxiety. The four 
distress-related symptoms from the HSCL-25 that participants reported the highest levels of 
suffering from were nervousness and unsettlement, sleeping issues, loneliness, and a feeling 
of hopelessness regarding the future. A larger proportion of exercisers than non-exercisers 
reported emotional distress, depression, and anxiety; the difference in emotional distress was 
significant (p=0.002).
Historically, more than 94% of participants had received inpatient SUD treatment at 
some point in their lives (31), and for an average of 27 months.  The majority  entered their 
current institution from another SUD treatment institution or detoxification program. 90% 
(28) had also received outpatient treatment, for an average of 40 months. 
75% reported using at  least one substance/medicine over the six months prior to the 
intervention. Half used at least two substances over the past six months, 40% used at least 
three, and 25% used four or more (participants were asked only for their four most 
commonly used substances). There was no significant difference (p=0.725) between the 
addiction severity of exercisers and non-exercisers. 
The most commonly used substances over the past six months were benzodiazepines 
(reported by 41% of participants), alcohol (38%), cannabis (28%), heroin/opiates (25%), 
amphetamines (25%), and opiate substitution drugs (19%). Three participants (9%) reported 
using performance-enhancing drugs. Similar proportions of active and non-exercisers used 
each substance. 
Nicotine-dependence was not assessed, but 77% of participants smoked daily. More 
exercisers (91%) than non-exercisers (60%) smoked. Among smokers, exercisers reported an 
average of 15 cigarettes daily, while non-exercisers reported 10. Snus, a product similar to 
American dipping tobacco but rare in the United State and banned in the European Union, 
was used by 26% of exercisers but 60% of non-exercisers. 
3.1.2	  QoL	  at	  baseline
Participants scored their social relationships QoL to be the lowest of their four QoL 
domains, and their environment QoL to be the highest. This pattern is seen among both 
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exercisers and non-exercisers. Exercisers rated their physical health, psychological health, 
and environment slightly lower than non-exercisers and lower than the total mean. Standard 
deviations among exercisers’ means were also slightly larger than for non-exercisers for 
physical health, psychological health, and social relationships. Exercisers reported 
significantly (p=0.025) lower QoL in the physical health domain than non-exercisers; the 
remaining three domains were normally distributed.
3.2	  Research	  Aim	  2:	  QoL	  changes
3.2.1	  Descrip9ve	  sta9s9cs	  
Measured on a 4-20 scale, average post-intervention domain means increased for 
exercisers in all domains, with the psychological health domain increasing the most (1.75 
points), social relationships increasing by  1.37, physical health by  1.27, and environment by 
1.18. Non-exercisers’ physical health decreased by  0.71, but their social relationships 
increased by 1.5. Psychological health and environment increases were more modest for 
non-exercisers at 0.59 and 0.50, respectively. The following section statistically analyzes 
these changes.
Table 3.2 QoL Domain score means
Baseline Follow-up
Total Exercisers Non-
exercisers
Total Exercisers Non-
exercisers
n=35 n=24 n=11 n=28a n=20 n=8
Physical health 12.3 
(SD=2.7) 
11.6 (2.7) 13.9 (2.2) 13.8 (2.2) 13.5 (2.3) 13.3 (2.2)
Psychological health 11.9 (2.1) 11.6 (2.3) 12.5 (1.6) 13.5 (1.6) 13.8 (1.8) 12.8 (1.0)
Social relationships 11.4 (2.7) 11.5 (2.8) 11.2 (2.5) 13.4 (2.8) 13.8 (3.1) 12.7 (1.9)
Environment 13.5 (1.9) 13.4 (1.8) 13.7 (2.2) 14.7 (2.7) 14.8 (1.9) 14.4 (1.4)
a  Three injured participants are excluded at follow-up. 
3.2.2	  Sta9s9cal	  analysis
A significant effect of the interaction between exercise and time was seen for 
physical health QoL (p=.005) and psychological health QoL (p=0.023). No significant 
effects of an interaction were observed for social relationships or environment QoL. 
Significant main effects of time were observed for the psychological health (p<.0005), 
social relationships (p=.034) and environment (p=.045) domains of QoL.
Overall this can be interpreted as follows: patients in SUD treatment experienced 
changes to the QoL domains psychological health, social relationships, and environment 
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during the 10 weeks of SUD treatment, regardless of whether they exercised. The exercise 
groups had an added and independent effect and resulted in a positive change of the QoL 
domain physical health in the exercise group only, and in an additional positive change in the 
psychological health domain in the exercise group only. 
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Thus the null hypotheses can be partially rejected and partially accepted, as we have 
examined the outcome in four domains. Exercisers’ physical health and psychological health 
domains of QoL increased significantly more compared to non-exercisers. The null 
hypotheses for these two domains may be rejected. All participants’ social relationships and 
environment domains of QoL increased, but there were no significant differences between 
active and non-exercisers’ changes, and hence the null hypothesis is accepted for these two 
domains. 
Exercisers’ improvements in the physical health QoL, psychological health QoL, and 
environment health QoL domains were above the minimum clinically important difference 
(MCID) threshold and therefore considered meaningful to exercisers; that is, these 
improvements are assumed to have been noticed and appreciated. This is despite the fact that 
only their physical health QoL and psychological health QoL increases were statistically 
significant. The entire cohort’s statistically significant improvements in psychological health 
QoL and environment QoL (attributable to normal SUD treatment) were above the MCID 
threshold. In contrast, the only  statistically  significant  improvement among non-exercisers – 
the social relationships domain – exceeded the MCID threshold. Non-exercisers’ decrease in 
physical health QoL was not above the MCID threshold, and therefore cannot be considered 
a meaningful decline. 
Table 3.3 QoL Domain score mean changes and MCID
Total
n=28a
Exercisers
n=20
Non-exercisers
n=8
Mean change 
(SDΔ)
MCID Mean change 
(SDΔ)
Mean change 
(SDΔ)
Physical health +1.3  (2.6) 1.3 +1.9* (2.0)  - 0.7  (2.1)
Psychological health +1.8* (1.6) 0.8 +2.0* (1.4)  +0.6  (1.4)
Social relationships +1.4  (2.8) 1.4 +1.4  (2.5)  +1.5* (3.8)
Environment +1.2* (2.0) 1.0 +1.3* (2.0)  +0.5  (2.2)
a  The domain scores of three injured participants are excluded.
* Clinically significant change
Abbreviations: SDΔ = standard deviation of change score; MCID = minimum clinically 
important difference, calculated as 0.5 SDΔ
The WHOQOL-100 MCID thresholds calculated by Den Oudsten et al among a 
cancer population were determined to be 1 for each domain, roughly corresponding to the 
range calculated here of 0.8 – 1.4. 
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3.3	  Research	  Aim	  3:	  Explanatory	  factors
QoL is a multidimensional measurement with numerous inputs, as described in the 
introduction. While exercising participants increased their physical health and psychological 
health domains of QoL with statistical significance compared to non-exercisers, changes in 
clinical variables that have demonstrated relationships to QoL were also measured. This 
section explores explanatory factors that may have been involved in QoL changes. None of 
the clinical variables could be added to the statistical analysis as covariates because one or 
more assumptions were violated, as described in 2.7.1 Quantitative analysis. 
3.3.1	  Changes	  in	  clinical	  variables
Psychological	  health
At the conclusion of the intervention, emotional distress, anxiety, and depression had 
reduced among exercisers, while non-exercisers experienced no changes. Exercisers’ levels 
of total emotional distress and of depression reduced to nearly  the cut-off point for normal 
findings. 
Soma@c	  health	  
At the end of the study, the only somatic condition to decrease in prevalence (from 
21% to 13% among non-exercisers, and 71% to 42% among exercisers) was impaired 
memory. One condition, respiratory problems, affected three more participants during the 
intervention than before. Most conditions affected the same amount of participants and to the 
same extent as before the intervention. Difficulty breathing was a common complaint during 
sessions, and always attributed by participants to smoking. 
Substance	  use
Substance use and variety after the intervention decreased across the board, with the 
exception of program-prescribed substitution drugs (such as buprenorphine or methadone), 
which the same amount of participants used before and after. While 22% of participants 
reported abstinence at baseline, that number nearly  tripled to 65% at the intervention’s end, 
with eleven more exercisers reporting abstinence and only one more inactive participant. 
Non-exercisers were more likely to report  substance use at follow-up: 62% used at least one 
substance compared to 26% of exercisers. Fewer exercisers smoked at follow-up (from 91% 
at baseline to 62%), but the proportion of non-exercisers remained the same (from 60% to 
57%). Exercisers who smoked also reduced their daily average from 15 to 9 cigarettes, while 
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non-exercisers cut down by one cigarette. Several participants reported substituting 
cigarettes with electronic cigarettes, but further data was not collected on e-cigarettes.
3.3.2	  Dose	  received
The dose of group exercise received, represented by  the amount of sessions attended, 
could also explain with finer detail QoL domain changes. The sample size was too small to 
explore a dose-response relationship statistically. Separating exercisers into three roughly 
equal groups according to attendance level reveals close to a descriptive dose-response 
relationship  in the physical health and psychological health QoL domains. In all domains, 
the most active exercisers’ averages increased more than the least active exercisers’. In the 
physical health, psychological health, and environment domains, exercisers’ averages 
increased more than non-exercisers’ averages. 
Figure 3.1 QoL changes by dose
3.4	  Research	  Aim	  4:	  Assessing	  acceptability	  and	  replicability
Acceptability  of the exercise groups to participants was assessed through integrating 
qualitative feedback on liked/disliked program aspects with attendance data. Feasibility/
replicability is assessed through reflections from myself and the other coach, as well as a 
break-down of costs and sponsorship. True to the qualitative research tradition, this section 
mixes qualitative results with discussion, although recommendations for best practices are 
reserved for 4. Discussion. 
-­‐0.70
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  health Social	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3.4.1	  Recruitment	  and	  assessment
Only three out of an intended 30 participants were recruited to the initial comparison 
group. This difficulty  may partly  be due to residents at two out of four institutional 
recruitment meetings being already interested in exercising, but the remaining two 
institutions’ recruiting meetings involved all residents, and most of those who were not 
interested were not successfully motivated to fill out the screening questionnaire. 
In one case, a participant who wanted to enroll into the exercise group did not 
complete the screening questionnaire and therefore was not enrolled because the mental 
health history questions disturbed him. His was the only situation in which the questionnaire 
directly  hampered recruitment, but many other participants expressed displeasure at the 
intimacy of the questions. The questions about recent and historical suicide attempts and 
substance use were the most unpopular; one staff member explained that suicidal 
experiences were common recent occurrences, while the substance use question was disliked 
by currently abstinent participants who did not want to reflect upon any  prior substance use 
and by using participants who were frustrated that they were forced to remember their usage. 
3.4.2	  Overall	  a_endance
A histogram of attendance among exercisers reveals a fairly even spread: while the 
range is from one to 27 sessions, between one and three participants attended nearly  every 
possible amount of sessions within this range. From this spread cannot be drawn a “magic 
number” of sessions which most participants liked/attended. 
Among the entire exercise cohort, institution 1 had the highest mean number of 
sessions (15 out of a possible 30), followed by institution 2 (14), institution 3 (13), and 
institution 4 (11). Attendance peaked in weeks one through four and week nine, with these 
sessions serving between 14 and 17 participants across the four groups.
Among exercisers, the most  common explanation for non-attendance was a lack of 
energy, expressed through the phrase “jeg orker ikke”. This explanation was occasionally 
supplemented with a further cause – a busy day, a challenging therapy session, new 
medication – but most often stood alone. Scheduling conflicts were the second most 
common reason for non-attendance, and most of the time they  were related to school or job 
training. In weeks five and six, four participants from institution 2 purchased memberships 
to a nearby  gym and their attendance decreased. Among non-exercisers, the most common 
reason for non-attendance was an expectation that the exercise groups would not  help, either 
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because the exercises were of too low an intensity or because the participants already knew 
how to train themselves.
There was no common activity  that produced higher attendance rates across 
institutions, but the activities themselves and the variety of activities was the most-liked 
aspect of the program. Given that each reminder SMS to participants contained the session’s 
activity, and that each group collectively decided upon the pattern of activities, participants 
were free to decline the activities that they did not like and attendance rates per activity can 
therefore be interpreted as a reflection of their preferences.  The figure below displays the 
relative popularity of four separate activity  categories (walking/running; ball sports; indoor 
or outdoor strength-training; or other, including yoga, laser tag, and kickboxing) in each 
institution, via the activities’ share of total participation. Walking/ running sessions were the 
most attended in institution 1, while institution 3 saw a nearly even split between walking/
running and strength-training. Institution 2 played ball sports most often, and institution 4 
was split between ball sports and strength-training. 
Figure 3.2 Relative activity popularity
The combination of staying on-site and with the normal coaches led to the highest 
attendance rates. Attendance did not drop  when a session involved leaving the site with the 
coaches (e.g. weekly  runs/walks around a lake in institution 1), but the fact that coaches 
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came to the participants was specifically  mentioned as a positive aspect. Attendance also did 
not drop when an external trainer came on-site (e.g. yoga), but the combination of both lead 
to sparsely attended sessions (e.g. laser tag and kickboxing). Some participants decided at 
the last minute to attend sessions after seeing their fellow participants assembled and 
greeting the coach. Staying on-site gave participants flexibility  and reduced the pressure and 
time commitment of mentally and physically preparing themselves to exercise. 
3.4.3	  Addi9onal	  popular	  program	  aspects
Several key programmatic elements were valued by  participants, as expressed 
through spontaneous feedback and the follow-up questionnaire. Specific activities and the 
variety of activities was already discussed as the most popular aspect. The second most-
mentioned aspect was that the sessions were of appropriate intensity and duration. Many 
participants – exercisers and non-exercisers – expressed embarrassment at their fitness levels 
and weights compared to before treatment. While several participants asked for more 
strenuous sessions mid-program, the low-intensity and 30-minute dose seemed to physically 
challenge, without overwhelming, the majority  of participants. Thirty minutes was a 
sufficiently short amount of time to not be intimidating, and coaches used the phrase “only 
thirty minutes” liberally when encouraging an ambivalent participant to attend or join in. 
Being trained by  a coach, and coaches’ attributes, were two related and repeated 
themes. Coaches were described as motivating, engaging, skilled, and kind. The 
independence of the coaches from the institutions was also valued, as two participants 
appreciated the confidentiality  of their conversations with coaches from their institutions, 
while several others said that they liked the fact that coaches cared enough to conduct this 
project – coaches were ostensibly not seen as constituents of their existing program staff. 
Exercising not only with a coach but also with each other was another popular 
aspect. Participants mentioned that exercising in a group made the exercises easier, that it 
motivated them, and that they simply liked the socialness. One participant also reported that 
post-exercise attitudes were different among her fellow participants: “People are happier. 
Our relationships with each other are better; there’s more laughter.” Another participant said 
that this group was the first time he had looked forward to exercising with other people. 
Coaches observed how participants motivated each other in ways that the coaches could not 
have, such as by  knowing that a particular participant would attend only if s/he was told by 
SMS how many others were already present, and importantly, by demonstrating through 
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example that their fellow participants needed congratulation and recognition of the smallest 
accomplishments. 
Seeing evidence of individual achievements or progress was not originally in the 
group design, but coaches quickly  began tracking individual progress at  several participants’ 
requests, and this was a well-liked aspect at follow-up. Incentives, the original method for 
recognizing achievement, were also received positively and mentioned often during follow-
up. However, it  is unclear whether they achieved their second goal of increasing attendance, 
as attendance did not increase in the sessions leading up to incentive distribution. 
Participant input being taken into account was also appreciated by  many. This 
included, first, setting times and a preliminary activity schedule suggested by participants at 
recruitment, and as the program progressed, included changing times, switching activities, 
and adding new activities. Participants relayed their requests and preferences to coaches 
during sessions and by SMS, and nearly every active participant reported liking the SMS 
reminders and/or overall communication with the coach.
Only two negative elements were identified. The intensity was described as too low 
by four participants (three of whom specifically  noted that the beginning few weeks’ 
intensity was appropriate, but should have increased thereafter) and as too high by two 
participants). Three participants also pointed out the activities that they wished were 
excluded. Combined with attendance data, it can be added that traveling off-site and to meet 
with an external trainer were also unpopular aspects.  
When asked to describe their experiences, participants responded positively. There 
were no negative experiences reported in the follow-up questionnaires, despite injuries and 
occasional frustration expressed at a participant’s poor physical form. In response to this 
question, participants identified six categories of benefits, most of which were physical. 
Improved fitness and other physiological benefits were reported the most, with examples 
given of better respiratory health, improved stamina during sessions, and more toning. The 
adoption of health behaviors beyond the exercise groups, such as reduced smoking, 
replacing elevators with stairs, and purchasing a gym membership, were also reported. 
Several participants said they learned new training techniques that they  would continue to 
use, and two said they  had more energy to fulfill daily  tasks. Among the psychological 
benefits were improved mood and motivation, both to continue training and to “get out  the 
door when I don’t want to”. Staff echoed the motivational benefit, and reported surprise that 
the program engaged certain participants who they expected to lose interest, and engaged 
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more participants who had been interested in exercising but who had no success beginning 
or maintaining exercise routines in the past. Mood-boosting effects were also noticed staff 
when they reported that participants liked and looked forward to sessions. 
The only session-caused injury was a topical scrape after a participant fell into the 
sand during sand volleyball. The scrape required rinsing and a band-aid. 
3.4.4	  Labor	  and	  cost
Implementation of these exercise groups was more labor-intensive than cost-
intensive. I led groups at three institutions, requiring around 15 hours of preparation, travel, 
exercise, data recording, and communication with participants each week, and hired another 
coach for the fourth institution. His group required more travel and therefore took six hours 
of his time each week. Communication between us required less than one hour each week. In 
sum, implementation of these four exercise groups took us an estimated minimum of 22 
hours weekly. 
This pilot study received 44 780 NOK (7 500 USD) of in-kind sponsorship from 
Norwegian companies, of which 28 290 NOK (4 735 USD) was utilized; and 8 771 NOK (1 
468 USD) of subsidies from SERAF. One institution covered their own costs of 5 938 NOK 
(994 USD), and I paid for the balance, less than 1 000 NOK (167 USD). Sponsored costs 
accounted for 65% of total costs, and institutional reimbursements were 24%.
The largest single expense was payment of the additional coach. Incentives involving 
gym memberships, such as the ten one-month memberships and ten personal training hours 
donated by Elixia Ullevål, were worth nearly as much. By category, incentives represented 
62% of the project’s total costs, while session-related costs were 25%, data collection costs 
accounted for 7%, and equipment for only 6%. The low proportion of equipment-related 
costs is a result of conducting the majority of sessions either in public spaces outdoors or on 
institution property, thus avoiding the need to rent space.  
Table 3.4 Costs by categorya
NOK USD
Data collection (e.g. follow-up dinners) 3 156 528
Sessions (e.g. yoga teacher, race entry fees) 4 910 822
Equipment (e.g. football, volleyball) 2 531 424
Incentives (e.g. gym membership, water bottles) 27 202 4 553
Additional coach salary 6000 1 004
Total 43 799 7 330
a Includes the prices of utilized in-kind sponsorship as well as goods and services 
directly purchased. Unutilized in-kind sponsorship is excluded.
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3.4.5	  Ins9tu9onal	  burden
The largest burden to institutional staff was when I recruited institutions and 
participants. Staff devoted the most time in the planning phase, when they met with me, 
reviewed the project plan and questionnaires, decided whether the project could be relevant 
to their residents, and facilitated the first recruitment meeting between myself and residents. 
Groups were conducted independently  after those meetings and staff did not need to attend 
sessions, donate equipment, or be involved in scheduling. That  being said, the institution 
with the highest attendance rate among exercisers was institution 1, with a dedicated staff 
member who attempted to attend at least one session per week, publicized sessions by 
posting the group schedule, prioritized the group by  not scheduling overlapping institutional 
meetings or events, and informed me when conflicts were unavoidable. 
4.	  Discussion
4.1	  Summary
To my knowledge, this is the first study that has quantitatively measured QoL in a 
SUD population before and after a voluntary exercise intervention. Statistical analysis 
revealed that  exercising participants experienced statistically and clinically significant 
increases in physical health and mental health domains of QoL compared to non-exercising 
participants, while exercise did not affect social relationships or environment domains. 
Given the methodological limitations of this study, exercise cannot be isolated as the sole 
contributor to QoL increases. The exercise groups succeeded in engaging participants with 
the worse physical and mental health, and design features that may  have contributed to 
making the exercise groups so accessible and appealing have been recommended as easily 
and affordably replicable features for future interventions. 
4.2	  Methodological	  discussion
4.2.1	  Theore9cal	  assump9on
Post-positivism as my  theoretical assumption means that I anticipated that  my own 
values, experiences, and expectations influenced all aspects of the design and 
implementation pilot study, including how I interpret those results. Rather than disregard 
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findings as invalid, post-positivism requires the identification and enunciation of such 
influences. 
4.2.2	  Design	  
This pilot study utilized a non-experimental design with an ex post facto group 
assignment, wherein participants who did not exercise over the course of the intervention 
were analyzed along with the three participants enrolled into the comparison group as non-
exercisers, and all participants who exercised were analyzed as exercisers (see 2.7 Analysis 
for further explanation). The sample was drawn from four public and private institutions 
providing residential SUD programs dispersed around eastern, western, and downtown Oslo; 
these were real-world instead of controlled settings. The four institutions were not selected 
randomly, but chose to be included in the pilot study by virtue of staff interest (an 
opportunity for sample selection bias that impacts external validity). Two institutions 
provided all of their residents for recruitment, while the other two pre-screened residents and 
only those residents who were interested (or perhaps encouraged) attended the recruitment 
meetings (sample bias).
4.2.3	  Internal	  validity
Validity concerns the goodness, or quality, of an inquiry. Post-positivism does not 
deviate from positivism’s realist ontological benchmarks of internal validity and external 
validity  to assess knowledge produced, but there must always be attention to the fallibility of 
such knowledge based on the theory  that it and the study  design was influenced by, the 
measurement that captured it, and the exceedingly  irremovable interplay of researcher-and-
participant [158].
Internal or causal validity is achieved when a researcher can assert that A (e.g. a 
treatment) caused B (e.g. an effect), “ceterus paribus”. Such assertion is never absolute 
within post-positivism, as only one falsification is required in order to disprove causality 
[159] An ambitious aim of this pilot study was to determine, within the design limitations, 
whether participants (divided by  the independent variable of group exercise) experienced a 
change in the dependent variable of QoL. Approaching a nonfalsified hypothesis of causality 
requires three conditions to be met, and this pilot study satisfied two of them [160].
First, measuring QoL after the exercise treatment had been received satisfied the 
requirement of time order, which requires the effect to be measured after the treatment. 
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Measuring QoL at baseline, before the exercise treatment, further allowed for more complex 
analysis of QoL at different time points. Second, there was an empirical association 
(correlation) between exercisers and changed QoL in all domains: if a participant exercised, 
QoL increased. As 3.2.2 Statistical analysis discusses, the improvements were only  unique 
to exercisers in the physical health and psychological domains, leading to the rejection of 
such association for the social relationships and environment domains. 
The final requirement of causality, non-spuriousness, is violated due to a number of 
challenges to internal validity that are often present in non-experimental designs. 
Nonspuriousness is met when no variable can be found that changes the association between 
treatment and effect. 
The sampling design itself leads to the first violation. Randomization was beyond the 
scope of this pilot study, although is the strongest method of ensuring internal validity 
because it enables the creation of two groups with the same random distribution of 
characteristics. Self-selection into the exercise or non-exercise groups instead of 
randomization is a major methodological weakness in this pilot study, because self-selection 
exposes findings to the obvious risk that any changes experienced over the course of the 
study are attributable to unexplored characteristics between the eleven participants who 
never attended a session and the twenty-four who did (e.g. motivation to exercise, self-
control, self-efficacy, etc.) – in other words, the positive associations of exercise and 
increased QoL domains could be spurious, as the design was not randomized. 
Knowing that the two groups may differ, three major characteristics that have a 
documented relationship  with QoL and could therefore influence QoL over the course of the 
pilot study - physical health burden, mental health burden, and addiction severity - were 
measured at  both baseline and follow-up. As 2.7 Analysis explains, adding these variables as 
covariates to the GLM would have been one way to analyze changes in QoL while taking 
probable influences into account, in an attempt to make the two groups more comparable in 
regards to the outcome. Simple tests of means of each variable revealed that, as a result of 
self-selection, exercisers and non-exercisers were in fact different in some aspects and hence 
not truly comparable groups in statistical terms, another violation of nonspuriousness. This 
does not prevent the utilization of the existing literature reviewed in 1.5 Exercise and 
physical activity about observed QoL levels and changes of non-SUD populations with and 
without exercise, and of SUD populations with and without SUD treatment. Each variable 
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will be discussed in 4.3.2.1 Engagement of the most suffering, as part of the discussion of 
who the exercise groups managed to engage. 
Exercisers and non-exercisers were housed together in institutions 2, 3, and 4, 
making group contamination a potential concern. Group contamination is seen if exercisers 
and non-exercisers, housed together in institutions 2, 3, and 4, influenced each other in ways 
that then led to QoL changes. A classic example would be if exercisers returned from 
sessions cheerful and with improved moods, thereby  contributing to improved moods 
throughout their institutions, including among non-exercising participants. The better milieu 
could have increased the social relationships domain of QoL of non-exercisers, perhaps 
explaining the equal gain in this domain across both groups. It is important to note that 
group assignment was fluid, in that the three participants who enrolled in the comparison 
group were told they were free to begin exercising at any time, just as those enrolled in the 
treatment group were free to not exercise. The group assignment used in analysis was 
different than what participants had expected: it was only during data analysis that the 
comparison and treatment groups were changed to the non-exercising group (containing the 
comparison group  plus the eight  participants who enrolled into the exercise group but never 
exercised) and the exercising group (containing only the participants who exercised). That 
participants were free to exercise or not, regardless of initial enrollment, reduces the 
likelihood of conscious group contamination, such as non-exercising participants feeling 
excluded and their self-confidence and subsequent psychological health QoL decreasing. 
 Measurement errors are possible but unlikely due to use of previously  validated 
instruments such as the WHOQOL-BREF to measure QoL and the HSCL-25 to measure 
mental health burden. One area of uncertainty  is the social relationships domain of the 
WHOQOL-BREF, which may not have been appropriate to a residential population such as 
this sample. The three questions comprising this domain – how satisfied are you with your 
relationships to others, the support you receive from your friends, and your sex life? - are 
perhaps less relevant to respondents living in an institution, whose majority  of relationships 
may be with other suffering patients, who may be isolated to some degree from their pre-
institution friends, and for whom sexual activity could be of markedly lesser occurrence. If 
this domain’s items were poorly equipped to measure social relationships QoL among a 
residential population, the impact of exercise could be masked by the model.  
The NorComt instrument was used to measure physical health burden and was 
unvalidated, although used in previous large-scale studies of Norwegian SUD patients. It is 
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also unlikely that it  failed to capture physical problems which were alleviated over the 
course of the pilot study and resulted in increased physical health QoL. Qualitative feedback 
during the study and at follow up  did identify three physical conditions that were 
underreported (thrombosis, causing leg pain and inflexibility) or excluded (intermittent 
claudication, causing muscle pain and cramping during exercise [138]; and epilepsy) from 
the questionnaires. However, seven exercisers and two non-exercisers reported a worsening 
of these conditions over the course of the study, not  an improvement. These examples do not 
support the suggestion that  a measurement error of the covariate physical health burden 
explains the increase of exercisers’ physical health QoL. 
Endogenous changes, developments independent to the exercise treatment, represent 
three additional threats to internal validity. The testing effect refers to how answering the 
same questionnaires at baseline and follow-up may have caused participants to alter their 
second answers. This effect is less applicable to the study’s questionnaires and particularly to 
the QoL tool, both because aptitudes were not being tested and because the QoL tool has a 
high internal validity, suggesting that multiple testing does not increase scores. The 
maturation effect is also a less applicable threat, as ten weeks is not enough time for aging/
maturation processes to change answers from baseline to follow-up. 
Regression to the mean is the final endogenous change and applicable to repeated 
measures analyses such as this. It refers to the phenomenon of a sample having an extreme 
mean score on the first test scoring less extreme on the second test, due to movement 
towards the mean, as any score is a combination of a that being measured, systematic error, 
and random error. All participants scored lower than average in every  domain of QoL at 
baseline (see 4.2.4 Generalizability), so increases in QoL at follow-up could, at first glance, 
be attributable to regression to the mean. However, this pilot study is not interested in QoL 
increases over time, but whether exercisers increase QoL over time in a manner significantly 
different than non-exercisers, and therefore both time and exercise assignment are included 
as variables in the GLM. The robustness of the GLM is that participants’ baseline scores are 
taken into account (as within-subject factors) when the model analyzes changes at follow-up. 
This discussion is only relevant to the psychological health domain, in which both groups’ 
QoL increased over time) (with statistical significance) and exercisers’ QoL increased more 
than non-exercisers (also with statistical significance). The improvement of both groups’ 
scores could be attributable to regression of the mean, if scores at baseline were very low 
only by  chance, although this explanation is not of particular interest to this study. But as 
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both groups began with statistically comparable QoL, it does not make sense that only 
exercisers would regress towards the mean more, and therefore the “extra” improvement can 
be attributed to exercise assignment. Regression to the mean is not applicable to the social 
relationships or environment domain, where exercising had no effect on QoL, or to the 
physical health domain, where non-exercisers’ QoL decreased over time. 
Regression to the mean is of more concern in the covariate of mental health burden. 
Exercisers began the study with a significantly larger mental health burden than non-
exercisers, and exercisers experienced a reduction in their mental health burden over the 
course of the study, while this burden did not change for non-exercisers. Exercisers’ mental 
health burden was still greater at follow-up  than non-exercisers’. Regression to the mean 
could explain exercisers’ non-exercise-related reduction in mental distress than may have 
prompted an improvement in psychological health QoL. 
Finally, two sources of treatment misidentification – when exercisers experienced 
additional “treatments” beyond group exercise, speaking to the value-ladenness of facts from 
both participants’ and researchers’ perspectives – are inapplicable to this pilot study. 1) There 
was no placebo given, and exercising was not an ambiguous activity. 2) The Hawthorne 
effect – when treatment group members feel special and therefore change in the dependent 
variable – is inapplicable because exercisers were not “chosen” to receive the treatment, as 
they  voluntarily joined the exercise group  just as non-exercisers voluntarily declined to 
exercise. Expectancies of experiment staff, the third source of treatment misidentification, is 
of ambiguous importance in terms of adding spuriousness. Experiment staff (the coaches) 
were intentionally positive and motivating as to the effects of exercise, and they emphasized 
tangible results such as less labored breathing, better sleeping, and less stress, not the 
outcome of QoL. But rather than considering such enthusiasm to create an unwanted self-
fulfilling prophecy, such positivity and high expectations were an intended program feature. 
Even though this pilot study’s treatment is referred to as “group exercise”, the treatment 
specified positive coach leadership  and involvement. 4.3.2 Feasibility is vital in discussing 
the importance of the coaches’ relationships with participants and similar program features 
that cannot be captured by the term “group exercise”. 
4.2.4	  Generalizability	  
Chambliss and Schutt [160] divide generalizability  into two aspects. Cross-
population generalizability, which they  equate with external validity, exists when one 
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population’s findings hold true for another population. If this pilot study was interested in 
exploring group  exercise’s effects on chronically ill populations, then the representativeness 
of this SUD sample to other chronically ill populations would be an application of external 
validity. 
The aspect more germane to this study  is sample generalizability, or how valid 
findings from this sample of SUD patients are to the SUD population in general. The study’s 
small sample size prevents any statistical claim of sample generalizability. Two types of 
selection bias further dampen sample generalizability: first, only pre-selected residents were 
available for recruitment into the pilot study  in two out of four institutions. Second, residents 
enrolled into the study based on their own interest (sample bias). Both aspects of this study’s 
selection and sampling method expose the risks that the residents of the institutions which 
allowed me to recruit were different from the institutions that declined, and furthermore, the 
residents who deigned to participate were different than those who refused. Any of these 
differences could make the sample in this pilot study different than the larger SUD sample. 
However, participants in this pilot study share characteristics with previous studies of 
Norwegian and American SUD patients in their mental health, physical health, and QoL, and 
in their lower scores in each of these categories than the healthy population. 
Demographically, men were slightly overrepresented (74%) compared to Norway and 
Nordic countries’ average of 67% males in SUD treatment programs [143].
Participants reported worse mental and physical health at baseline than in non-SUD 
population [133, 161-163], validating previous surveys of SUD patients [14, 142]. Whereas 
only 11% of Norwegians have clinical levels of emotional distress [162], 55% of participants 
in this study were emotionally  distressed, the same amount found by Ravndal and Laurizen’s 
cross-sectional study  of Norwegian SUD patients [14]. Physically, every  participant reported 
at least one somatic disease or problem, compared to 37% of the general population [163]. 
Participants also reported worse QoL in all domains at baseline than healthy 
population norms from Denmark and Australia [161, 164], again validating prior studies 
[165]. The social relationships domain received the lowest score, followed by psychological 
health, physical health, and environment; this pattern mirrors the general Norwegian 
population’s ranking of QoL domains [133].
Despite the sample sharing similar demographic and clinical characteristics with the 
overall SUD population, a larger sample would be needed to establish non-difference and 
therefore increase external validity. A larger sample may  also increase the chances of normal 
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distributions of clinical variables among exercisers and non-exercisers, instead of the 
skewness towards exercisers that was observed in this study. 
The context of research is an important factor in a post-positivist assessment of both 
internal and external validity. The setting and time/history  of this pilot study  – three public 
and one private residential SUD treatment institutions, conducted in late summer and early 
autumn and without any  new political or policy discourse or changes around SUD treatment 
or QoL research – do not pose challenges to sample generalizability. The geographic 
dispersion of the institutions within Oslo and real-world settings of the treatment may even 
contribute to such generalizability. 
The greatest threat to sample generalizability of program findings is the novel nature 
of these exercise groups, both in terms of its flexibility and attention to participant 
accessibility and in the equally flexible and positive engagement of coaches. By nature of its 
novelty, this pilot study sought to develop a tailor-made intervention and produce 
suggestions for future interventions. In 4.3.2 Feasibility, I will argue for several design 
features that  I think are partly responsible for its success, and I believe these features must 
be at least replicated and preferably strengthened in future interventions. 
4.2.5	  Summary
The non-experimental design of this pilot study and inability  to use statistical control 
to account for possible confounding variables due to a low n limits claims of causal validity. 
Exercisers and non-exercisers were different at baseline in many variables that have 
established impact on QoL, therefore the impact of these variables – rather than exercise – 
could explain QoL improvements. The ability  to answer the second research aim is reduced. 
It is tempting to interpret results as evidence that group exercise positively increased two 
domains of QoL, but this intervention must be replicated in a larger, experimental trial. 
Concurrently, self-selection has its own benefits: it forms a clear picture of whom the 
exercise group appealed to versus whom it did not. This provides useful information that can 
help  future programs target those who liked this program, and/or adjust the program to 
appeal to a wider variety  of patients, helping to robustly  answer the fourth research aim. The 
trade-off of self-selection seems to be that we learned the characteristics of the SUD patients 
interested in an exercise group, but lost the statistical ability to control for these 
characteristics when assessing treatment effect.
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4.3	  Results	  discussion
This section will discuss the significance and novelty of three categories of results: 
which effects on QoL were visible, who among this SUD sample the exercise groups 
engaged, and programmatic aspects that may be of interest to institutions designing or 
implementing similar interventions. 
4.3.1	  Effects	  on	  QoL	  
Overall, this pilot  study  provides further evidence that exercise can be used as an 
intervention among chronic disease populations to boost  selected QoL domains, as meta-
analysis of interventions among cancer, cardiovascular disease, neurological, obese, and 
pulmonary patient samples demonstrate [46, 87, 90]. Two domains of QoL increased over 
time for exercisers, while two did not change. This section explains the significance of these 
improvements and integrates alternative explanations. The study of other potential mediating 
effects, such as the psychological outcomes of positive affect or self-efficacy described in 
1.4 Quality of life was beyond the scope of this project.
Improved	  physical	  and	  mental	  health	  QoL	  among	  exercisers
To my knowledge, this is the first study that quantitatively  measured overall QoL in a 
SUD population before and after an exercise intervention, and the first that estimates a 
minimum clinically important difference in the selected QoL tool. While one recent pilot 
study in Denmark qualitatively described increases in QoL after an exercise intervention 
[166] and an ongoing RCT in the United States called the STRIDE study will measure 
HRQOL of stimulant abusers after an exercise intervention [104], this pilot study provides 
quantitative evidence that  exercise increased the physical health and mental health domains 
of QoL with both statistical and clinical significance among this small sample.
The GLM with repeated measures revealed that the interaction of time and 
participation had a significant effect on, first, the physical health QoL domain: exercisers’ 
physical health domain of QoL positively increased over the course of the pilot study 
compared to non-exercisers, with statistical significance. After only  ten weeks, and for an 
average of 13-14 training sessions, exercisers were happier with their physical health realm 
of quality of life. This finding supports Martin et al’s finding that even a low dose of 
exercise can positively impact HRQoL among sedentary women [89], but is the first study 
that has measured this association among the SUD population., QoL increased among 
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exercising participants even without concurrent health improvements and in the presence of 
injury. Physical health QoL also increased among exercisers with a heavy burden of mental 
suffering.  
Physical health QoL improvements cannot be attributed to improvements among 
measured physical health conditions. All participants reported nearly  the same amount of 
physical problems and the same degree of suffering at  the start and end of the pilot study, yet 
exercisers were more satisfied with their physical health after the exercise program. The high 
prevalence of enduring physical conditions such as headache, tooth/gum problems, and 
dizziness is unsurprising; they  may be connected to medications such as substitution 
treatment or may be side effects of substance use, such as tooth loss and gum disease 
resulting from cocaine, heroin, and methamphetamine use. Some of the somatic conditions 
reported by exercisers (e.g. reduced memory) [167] may be alleviated after a short-term 
exercise intervention, while others (e.g. respiratory problems [168], joint pain, headaches) 
have fewer or unclear expected mitigations after such a short program. Group  exercise did 
not reduce the extent  to which anyone suffered from each problem, but it lessoned the 
significance that exercisers assigned to these problems, as expressed through their QoL. 
Physical health QoL also increased despite numerous reports of injuries. Participants 
were asked on the consent form if they had any known physical condition that could prevent 
them from participating (which none identified), but they  were not asked at follow-up if they 
became injured over the course of the intervention. Aside from the three participants who 
were excluded from statistical analysis because they cited a severe injury as the reason for 
complete non-attendance, ten additional participants reported that an injury or health 
problem impacted their participation in some way. Injuries did not linearly lead to less or 
non-attendance. While some of these ten participants skipped a few sessions until they 
recovered, others conducted modified versions of what their group was doing, and others 
requested and received entirely different sessions. Possibly the worst injury  of the analyzed 
participants was a broken wrist, and that participant only missed one session because of it. 
The participant requested modified sessions thereafter, and her/his group decided to replace 
the remaining sand volleyball sessions with running. It  was impossible for me to ascertain 
whether participants’ injuries were attributable to exercise (the broken wrist in question was 
decidedly  not), both because of my lack of medical knowledge, and because of the existence 
of pre-existing conditions such as intermittent claudication; participants themselves may  not 
have been sure about the cause of their injury. 
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One of the most commonly self-identified benefits of the exercise groups was 
improved fitness or other health measures. Changes in fitness were unmeasured, and could 
have increased by some other mechanism among exercisers and thereby attributed to the 
QoL increase in the physical health domain. Fitness was intentionally not measured so as to 
not dissuade potential participants who felt particularly  unfit, and to keep the focus on the 
socialness of the groups. When observed progress on physical fitness was relayed to 
participants in order to increase motivation, a few participants who identified themselves as 
being previously very  fit responded negatively, comparing their current fitness level to a 
prior level (prior either to SUD or to SUD treatment)3. A future intervention could measure 
fitness instead beginning at week two – after participants had familiarized themselves with 
the trainers – and/or only for interested participants, and again at follow-up. 
As found by previous studies, SUD treatment itself appeared to have a positive 
impact on psychological health QoL, as this domain increased over time in all subjects with 
statistical and clinical significance [12, 169, 170]. Psychological health QoL among 
exercisers also increased more than non-exercisers. This finding is encouraging, as it  mirrors 
the positive, exercise-induced QoL benefits related to mental health among healthy and other 
chronic disease populations reviewed in 1.5.2 Relationship to QoL. If SUD patients undergo 
the same sort of psychological QoL benefits after exercise as, for example, cancer patients – 
a population for which far more interventions attempting to increase QoL have been 
performed – the possibilities for knowledge transfer between interventions in each 
population can be exploited to a greater extent than they are now.  
The mediation of mental health burden on psychological health QoL is likely [171, 
172]. Exercisers’ mental health burden reduced over the course of the study, consistent with 
several meta-analyses and reviews of mental health outcomes after exercise interventions 
[173-175], while non-exercisers’ mental health burden remained exactly the same. 
Regression to the mean could explain this difference because non-exercisers’ mental health 
was at a sub-clinical level and exercisers’ was not, as could exercise itself, or an unmeasured 
factor. 
3 Indeed, physical health QoL was the only domain in which time did not have a statistically 
significant effect; that is, physical health QoL did not increase over the course of the pilot study for 
the entire cohort, regardless of exercise. SUD treatment programs are renowned for a lack of 
attention paid to the physical self insofar as SUD effects are not directly identified, and numerous 
subjects mentioned that the their activity levels and fitness had decreased during treatment. As one 
participant remarked when discussing his/her change in fitness, “you can tell if someone went to 
rehab by how fat they got.” 
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A final confounding factor of both QoL domains could be addiction severity, as 
measured by  the amount of substance used at baseline and follow-up. Both groups began 
with equivalent levels of addiction severity and this severity reduced among all participants, 
but the reduction was the largest among exercisers. Exercisers’ larger reduction could have 
been caused by an exercise-independent factor, and both groups’ QoL may have increased as 
a result of less substance use. 
No	  changes	  in	  the	  social	  rela@onships	  or	  environment	  domains	  of	  QoL
Part of my hypothesis that participation would increase the social relationship 
domain of QoL was based on a two-part assumption that participants possessed a paltry 
social network that could benefit from supplementation. The social relationship QoL domain 
increased almost exactly the same amount for exercisers as for non-exercisers, which could 
have been caused by  several pathways: First, the social contact provided by  the exercise 
group did not lend any benefits to exercisers’ social relationship  domain. Either they did not 
value the relationships they built in the groups, or additional relationships with exercising 
residents were not beneficial because fellow residents were struggling with similar problems. 
Second, a ceiling effect may have been observed, wherein participants already  had a 
minimum amount of social contact at baseline and additional contact provided via the 
exercise groups had only marginal effects on social relationships QoL. This explanation is 
anecdotally supported by  the larger amount, compared to my expectations developed in 
America, of structured and unstructured social activities in which participants partook. 
Several exercisers reported missing sessions to see friends or family, and sessions were 
occasionally rescheduled to accommodate formally  organized activities such as group  day 
trips. Third, exercisers could have benefited socially from the exercise group, but this gain 
was offset by decreased engagement with their existing social network, resulting in a null net 
change in social relationships QoL. Fourth, as described in 4.2.3 Internal validity, the QOL 
instrument may not be sufficient for measuring the social relationships domain of 
institutionalized patients. The popularity  of the group/social aspect expressed through 
qualitative feedback suggests that the exercise groups were at least enjoyable on a social 
level, despite no change in this aspect of their QoL that can be attributed to exercise.  As 
participants’ social relationships QoL was still lower at  baseline and follow-up than a healthy 
population, it would be unwise to deem supplementary social contact unnecessary.
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Participation did not impact the exercising participants’ environment domain of QoL 
in any  significant way, which is unsurprising, given that no aspects of their environment 
were changed by  the program. Only  one out of eight items measuring environment appear 
related at first glance to the exercise group: “to what extent do you have the opportunity for 
leisure activities?” 
4.3.2	  Feasibility	  
4.3.2.1	  Engagement	  of	  the	  most	  suffering
Given self-selection, it is expected that exercisers and non-exercisers would differ 
from each other. In the main outcome, QoL, the groups reported statistically non-different 
scores in three out of the four domains at baseline. The statistical analysis chosen was in any 
case robust enough to allow for the statistical difference in the physical health QoL domain. 
Surprisingly, participants with the highest mental and physical health burdens 
selected into the exercise group, not out. Mental and physical health burdens were different 
with statistical significance between the two groups, preventing either measure from being 
added to the analysis as a covariate. This finding differs from numerous studies among non-
SUD populations that show exercise is taken up  by  those with the fewest mental and 
physical health problems, and that exercise intervention drop-out is predicted by  physical 
health problems [176, 177]. And while the general population is less mentally distressed and 
more physically  active than the SUD population, those with the worst mental health among 
this sample of SUD patients actively engaged in the exercise program.
Rather than contradicting these studies, this pilot study’s findings provide 
preliminary evidence that an exercise group, designed to encourage and reduce barriers to 
attendance, can be appealing and maintainable to the physically unhealthy  and mentally 
suffering. I assume that institutions did not pre-select certain participants or discourage 
others (although this may have happened without my knowledge), because those who 
exercised were not  always the ones providers expected to succeed in the program. At three 
institutions, providers expressed satisfied surprise over one or more exercisers who they 
“never thought would stick with it”. The success of these exercise groups in engaging the 
worst off is an encouragement to institutions to extend an adjunct treatment such as exercise 
to a variety of patients, and not  only  to those judged to be physically or mentally  capable or 
ready. It is important for treatment providers to not allow personal or clinical judgments of 
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“readiness”, even those based on mental and physical health metrics, to become self-
fulfilling prophecies expressed in how they extend opportunities for innovative therapies. 
A variety  of explanations for the appeal of exercise groups to those with the worst 
mental and physical health problems exist. Perhaps the simplest is that  those who felt the 
worst, emotionally, were also open to more potential opportunities to feel better. This 
explanation assumes participants had an expectation of the mood-increasing benefits of 
exercise. In the same way, those with the poorest physical health may have expected exercise 
to have positive, alleviatory effects on their physical conditions. Poorer physical/mental 
health may have also been a proxy for separation from the labor market – exercisers were 
four times more likely to be both unemployed and not studying than non-exercisers – and 
such separation gave exercisers more free time in which to participate. This latter 
explanation is unconvincing, given that all participants at the enrollment stage set their 
group’s schedule, and the alteration of a session’s time and even date in order to 
accommodate a change in a participant’s work, school, or therapy  schedule was a common 
occurrence. It is possible that I am overestimating the accessibility  of these exercise groups 
and the willingness of participants to request  changes, but an important design feature was 
flexibility in order to maximize attendance, leading me to believe that  each exercise group 
could have met the needs of even the busiest participants, if they were interested.
4.3.2.2	  Acceptability	  to	  par@cipants
Acceptability  to participants was demonstrated through exclusively positive feedback 
regarding their experiences. The lack of negative experiences, even when given through 
anonymous questionnaires, could reflect their sensitivity towards the coaches as much as a 
paucity of areas of improvement. Positive feedback also suggests that participants’ 
expectations of the exercise group benefits were at least met and possibly  exceeded. Gillison 
et al [46] found that subjects exercising for chronic disease management as opposed to 
rehabilitation or prevention improved their physical health QoL but declined in their 
psychological health QoL. They  proffer that the chronic disease subjects’ expectations of a 
novel and hopefully effective treatment may  have been unrealistically high, “resulting in a 
negative impact on mood and emotions”, even while recognizable physical benefits were 
conferred. If exercisers’ psychological health QoL gains are interpreted according to Gillison 
et al’s hypothesis, participants of this pilot study appear to have been satisfied by their 
experiences. 
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Participants were, without exception, kinder to coaches than the coaches expected, 
and relationships beyond participant-coach developed over the course of the study. The roles 
and impact of the coaches are therefore even more vital to discuss, via the qualitative 
research tool of reflexivity: working with vulnerable populations such as the chronically ill 
already elevates the likelihood that participants provide program evaluation and reflections 
that they expect their coaches to hear, and contact and relationships between participants and 
coaches (as researchers) adds to the likelihood that such evaluation is made with their 
audience in mind. I do not expect that participants were any less rational or honest than 
participants of a large, randomized study that minimized social contact researchers might be, 
because the presumption of rationality and unbiasedness does not underpin this study. 
Rather, coaches’ relationships with participants developed into a program feature that must 
by identified and explored.  
For example, beginning with some participants’ interests in the design of the four 
exercise groups and in my motivation for conducting them, conversations about my 
background and reasons for moving to Norway developed. Over the course of ten weeks, 
many participants were aware of the importance I attached to the exercise groups and 
expressed this through complimenting the amount of time I spent traveling to each one, the 
amount of effort I used organizing, and so on. I can easily imagine that these same 
participants refrained from giving negative feedback that they  may have contemplated. The 
lesson to draw from this is not to discount participant feedback in order to compensate for 
their sensitivity towards the coaches, but that investment by the coaches is an important 
design feature that impacts participants.  
The manner by which these relationships developed was through a far larger degree 
of contact between coaches and participants than any study design could have prescribed. 
Some participants maintained a boundary  between themselves and the coach, while others 
gladly talked for thirty  minutes after sessions about topics unrelated to the exercise groups. 
SMS reminders provided a gateway for further communication and investment, as some 
participants gave more information about themselves and their lives over SMS than they did 
in person. Coaches used these offerings of information to follow-up with participants about, 
for example, how a recent family meeting went and if a new class schedule seemed 
manageable. Coaches’ contact  with participants was not limited to 30-minute sessions, and 
this had several results: as discussed above, it formed relationships between coaches and 
participants and transmitted coaches’ investment to participants; and at the most topical, it 
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reminded participants that they would always be welcome at a session, even if they had 
missed previous ones. This contact seemed to play an important role in participant 
motivation.
The elevation of the coaches as trained, physically fit specialists over their physically 
unfit participants, not to mention the setting of the groups which signaled participants to be 
patients undergoing treatment for a disorder, created an immediate power difference which 
needed to be recognized by coaches and the author of this study at the start, negated during 
the study, and taken into account as much possible during analysis. This power difference 
was acknowledged by participants-to-be when I pitched the idea of the exercise groups to 
one of the institutions. Two residents had been selected by  institution staff to provide input 
on behalf of the their fellow residents, and after giving me feedback on the types of activities 
they  would like and on the burden that answering the questionnaires might be to some 
residents with learning disabilities, their final suggestion was to have a coach “more like us, 
and less like you. Maybe a little fatter?” This jestful reference to the difference between our 
physical fitness was the first indication that I needed to talk less during recruiting meetings 
about my qualifications, and that I – despite being smaller, younger, and foreign, 
characteristics which I expected to damage my credibility  unless buttressed by coaching 
qualifications – could be intimidating or alienating.
An unexpected amelioration of some of the coach-to-participant power difference 
occurred through language. Both I and, coincidentally, the hired coach were non-native 
Norwegian speakers, and after the first week or two of getting to know the participants, they 
became comfortable enough to tease us for our language mistakes. Participants often 
corrected my language when I described a day’s session, and some appeared to enjoy 
teaching me; these participants made a point of asking me if I understood what they had 
said, and spelled out a particular word or took pains to explain a concept. When I thanked 
two participants who particularly  liked “tutoring” me and added that I furthermore enjoyed 
the positive social contact of the groups, one responded, “I’m glad you’re getting something 
out of it too, and it’s not  just us.” The other added, “That’s important.” The coaches’ 
imperfect language skills may not have negated the power differential of coaches holding 
instructive, inherently more knowledgeable positions, but it  did open a channel of 
reciprocity, wherein participants became the correctors and teachers, the ones holding the 
power to either encourage or discourage. Indeed, Johansen et al’s development of a social 
support model of SUD recovery (wherein a recoverer has a relationship with a sponsor) 
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suggests that recoverers benefit from being able to help  their sponsor in some way, and that 
attention to power differences can be paid through “giving the less secure individual position 
to contribute to the relationship” [39].
 I cannot envision an alternative design that further reduces the power differential 
between coaches and participants, as the former must necessarily  possess fitness training. 
Rather than recommending all future coaches have a handicap such as an imperfect grasp of 
their participants’ language, coaches must simply be well-trained to respect their participants 
as complicated, sensitive individuals, with whom coaches are working, not about whom 
coaches are studying. Allowing opportunities for participants to set their own physical goals 
and for coaches to learn from participants – such as when participants taught me how to play 
sand volleyball and floorball/innebandy – appears to have helped create “mastery 
experiences” in which they “were of use” to me as a sponsor and I was then able to affirm 
those activities, to again borrow from Johansen et al’s model [39].
Utilizing motivating and engaging coaches to supervise sessions are two design 
features that likely  attributed to the groups’ appeal to the physically and mentally  worst off. 
Several additional features related to increasing to participants’ motivation to attend and 
exercise: the group aspect, low-intensity (at least in the beginning), and feedback to 
participants of achievements and progress. Motivation to attend and to exercise are not 
entirely  the same. Some exercisers attended even when they were not in the mood to 
exercise, because a) they  felt  an obligation to their coach, either in general or after having 
responded to a reminder SMS positively; b) they  showed up only to explain their non-
attendance and were convinced by their coach to participate; or c) they  were forcing 
themselves to exercise despite not wanting to. It is clear that  the exercise groups were more 
than exercise groups, as participants attended for reasons other than to exercise. 
The importance of motivation during sessions cannot be understated. It was the 
program benefit most identified by participants as well as the characteristic most commonly 
ascribed to the coaches. Roessler et  al wrote about a similar finding in their pilot study of 
SUD patients participating in a running program. Even though running itself was the explicit 
focus and the study took place in a laboratory setting, without emphasis on the socialness of 
the exercise or interactions between instructors and participants, instructors’ “informal 
conversations with the patients showed to be very important to create a motivational 
environment...the feedback of the instructor and the other group members increased the 
dedication and commitment” [109]. Providing such constant  motivation was a strain on the 
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coaches and one for which we were not prepared or trained for, and each of us felt burned 
out after six or seven weeks of being relentlessly positive. 
Nevertheless, one benefit of a lack of SUD-patient-training on the sides of the 
coaches was that I can confidently claim to have not created any self-fulfilling prophecies 
that underestimated participants’ abilities. I was surprised by the poor physical form of 
participants in the first  few sessions, and while I hope I did not embarrass them with my 
surprise, I do not anticipate that any participants exercised “down” to a level that  I expected 
of them. 
Volunteers, whether recruited volunteers from the community  or institution staff, 
were also an enormous help, as they  lessened the burden on coaches to single-handedly 
encourage and engage multiple participants. Recruiting volunteers was more difficult than I 
anticipated and the only institution that was interested in and received volunteers appeared 
ambivalent about them. Solutions to future interventions could be to hire one coach per 
group, or to maintain multiple groups per coach, but to train coaches in basic motivational 
techniques. Despite no program-attributable increases in participants’ social relationship 
QoL domain, the group aspect of the exercise groups was a popular program facet. It was 
important for a participant to see that s/he was not  the only  one in poor shape, and I was 
surprised at the level of encouragement and motivation they gave to each other. To this end, 
exercising with fellow SUD patients appeared to be a better environment for many 
participants than exercising with external volunteers. 
Behavioral adherence techniques have been widely explored in exercise interventions 
among the overweight and obese but seldom among the mentally ill or those with a SUD, 
perhaps reflecting researchers’ greater uncertainty of exercise success among the latter than 
former clinical groups. Most successful design features in this pilot  study that were related to 
motivation were borrowed from behavioral adherence techniques within exercise-for-
weight-loss literature, providing further proof that  exercise interventions for the SUD 
population should not hesitate in borrowing best practices from successful exercise 
interventions with other populations. 
The second grouping of design features served to make the exercise groups as 
accessible as possible, namely, removing the need to travel, setting session times according 
to participant schedules, sending reminder SMSes before every session, and coordinating 
with institutions to avoid schedule conflicts. This last feature was implemented only in 
institutions 1 and 3, which had an increase in average attendance over time, while 
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institutions’ 2 and 3 saw attendance decrease. Institution 1 had one staff member who 
attended half of all sessions, kept sessions on her calendar and reminded participants, 
avoided scheduling treatment-related events concurrently, and informed me in advance when 
conflicts were unavoidable. Institution 4 had one staff member who attended one-third of 
sessions, the same day each week, and alerted all participants as to this day. In contrast, it 
behooved participants in institutions 2 and 3 to alert me as to upcoming conflicts with 
institution meetings, which in turn required a higher degree of commitment to the program 
and organization from these participants than from the others. While a degree of 
independence between myself and their institutions seemed appreciated by at least two 
participants (those who liked that their conversations with me were confidential from their 
institutions), the exercise groups would have been more accessible to participants had the 
coaches and the institutions collaborated more. These four features are easily  replicable 
design features. They are unusual in exercise intervention literature, because they require a 
commitment to participant accessibility  and more flexibility from the researcher/coach’s 
side. 
4.3.2.3	  Implica@ons	  and	  recommenda@ons
Many of the methodological limitations discussed in 4.2 Methodological discussion 
that challenge non-falsified causal validity can be alleviated through a proper experimental 
design. Random assignment into control and treatment groups would yield statistically  non-
different groups, allow for the subsequent inclusion of covariates into statistical analysis, and 
reduce the need to qualify results based on potential confounding variables. Control groups 
selected from different institutions than treatment groups would further reduce group 
contamination. Finally, a larger sample size could also pay more attention to possible 
subgroup differences by focusing on gender, race/ethnicity, or primary substance used.
A future randomized control trial should contain at least 200 participants; 100 
receiving the exercise treatment and 100 in a control group. Sample size calculations shown 
on Appendix 7 [178] calculated with the MCID of each domain suggested 128 participants 
(64 in each group) is a sufficient amount to conduct  an analysis, but taking attrition into 
account, a trial of at least 200 would be a safer way to ensure useable data from the 
necessary  128 is collected at both time points. An RCT of this size could produce further 
evidence of the statistical and clinical effect of group exercise on participants’ QoL.
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This pilot study speaks to the importance of holistic SUD treatment. This offer – a 
social exercise group lead by coaches outside of participants’ normal SUD treatment system 
– aimed to provide participants with a supportive environment, physical exercise and 
confidence, and novel activities in a way  that  then led them to more highly value their 
specific abilities and situations. Participants had additional access to guided meditation and 
mindfulness courses, yoga, activities in nature, equine-assisted therapy, art therapy, and 
courses in Christianity, as indicated by pamphlets and flyers in the various cooperating 
institutions. However, with the holistic outcome of QoL emerging as a clinically meaningful 
protective measure and goal of SUD treatment, further services could be added to the 
treatment field. Services such as nutrition and healthy-eating guidance, additional spiritual 
counseling, message therapy, and biofeedback could focus on further aspects of SUD 
patients’ lives that have negatively affected by  SUD, provide patients with supplementary 
skills and strengths on their recovery paths, and, ultimately, serve to improve QoL at 
whichever stage of treatment or recovery patients find themselves. 
The success of the pilot study  in improving exercisers’ physical health QoL and 
mental health QoL can be attributed to four broad categories of design features, with some 
overlap, that I recommend future interventions replicate and strengthen: 
1. Motivational techniques: For most participants, beginning a regular exercise program 
was physically  difficult and a challenge to garner enough energy and motivation for. 
Motivating participants to attend involved counteracting any negative reactions or 
expectations to the groups, and making the groups engaging and interesting. 
a. Group  exercise: exercising with peers made the sessions more enjoyable and 
approachable than one-on-one personal training sessions may  have been. 
Larger groups also allowed for a variety of group sports. 
b. Begin with a low intensity: the vast majority  of participants were physically 
unfit and smoked, which made breathing difficult even while walking.
c. Incorporate a variety of activities
d. Regular feedback about progress and accomplishments: notifying participants 
in person or via SMS of any positive aspects of their participation made it 
clear that even their participation was recognized and appreciated. 
2. Maximizing accessibility: Qualitative research among chronically ill populations has 
identified even more barriers to them than to healthy populations when beginning 
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and maintaining an exercise program, such as a lack of program elements practically 
tailored to their particular situations or limitations, and the stigma or embarrassment 
felt  by exercising among healthier individuals [179, 180]. Making the exercise 
groups accessible to participants therefore means attention to participants’ treatment 
schedules, physical and mental conditions (particularly poor memory), uncertainties 
and discomforts, and more. Such attention must be balanced by not creating self-
fulfilling prophecies. Removing barriers that other studies have identified is highly 
recommended. 
a. Use participant preferences to plan schedules and activities, and make 
ongoing adjustments as requested: this requires a large amount of flexibility 
and dedication to serving participants.
b. Session reminders and open communication between coaches and 
participants: SMSes and informally meeting with participants both before and 
after sessions are easy, affordable communication mechanisms.  
c. Coordinate with institutions to avoid scheduling conflicts
d. Remove the need for participants to travel or pay
3. Coach roles: Coaches should necessarily hold roles beyond those of skilled trainers. 
They  could benefit from basic training in motivational techniques and/or in pre-
exposure to this population’s unique characteristics. 
a. Motivation
b. Relationship-building with individual participants
c. Attention to and engagement with participants as equal group members, not 
patients or subjects: attention to power differentials through constant 
reflexivity.
4. Institutional involvement:
a. Add exercise group screening tools to institutional intake forms, to increase 
enrollment into at least the comparison group. Alternatively, staff 
encouragement to enroll.  
b. Review questionnaire content to identify  potentially triggering questions and 
provide support to participants while answering the questionnaires. 
c. Publicize exercise group schedules: e.g. posting physical schedules in 
common areas, reminding residents during institution meetings. 
d. Communicate with coaches to handle schedule conflicts in advance. 
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5.	  Conclusion
5.1	  Conclusions	  of	  the	  pilot	  study
The aims of this thesis were both scientific and procedural. Scientifically, the 
objectives were to evaluate changes in SUD patients’ QoL who participated in a coach-led, 
group exercise intervention for ten weeks, and to explore the role of group  exercise in 
addition to other factors in explaining these changes. The exercise groups appeared to 
increase, with statistical and clinical significance, exercisers’ physical health QoL and 
psychological health QoL. Simply undergoing ten weeks of SUD treatment increased all 
participants’ psychological health QoL, social relationships QoL, and environment QoL. The 
physical health QoL domain was unique in that non-exercisers’ QoL declined over time, 
suggesting that the exercise groups provided positive effects here that usual SUD treatment 
could not. The uneven distribution of clinical variables between exercising and non-
exercising participant made it  impossible for the study to determine if QoL changes were 
due purely to the exercise group and not to other measured or unmeasured factors. 
Procedurally, this thesis intended to design and implement these exercise groups and 
evaluate their feasibility and replicability. The voluntary  group exercise regimen was well-
received by this sample of sedentary  SUD patients, and a set of affordable, easily  replicable 
recommendations were made for the implementation of a future intervention: exercise 
should remain a social activity, involve motivating and engaged coaches, engage the 
treatment institutions, and incorporate with flexibility  participants’ preferences in order to 
maximize accessibility to them. 
A unique accomplishment of this study  as an exercise intervention was to attract 
participants with the highest burdens of physical and mental suffering into the exercise 
groups. These characteristics along with other baseline data collected can be used in the 
targeting of future interventions within SUD populations. The impact of QoL improvements 
after such a short intervention may be of interest to other SUD institutions, such as those 
providing outpatient services, and to institutions serving patients with dual diagnoses. 
Among institutions that offer such interventions, even without a pre-existing emphasis on 
QoL, this knowledge can be propagated to patients to allow them to make the most informed 
choices to participate. 
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Both the scientific and procedural findings of this pilot study encourage knowledge 
transfer. Exercise improved these patients’ physical and psychological health QoL as other 
studies have shown it to do among different clinical subpopulations [46, 87, 90]. Similarly, 
the successful motivational techniques and behavioral adherence factors utilized were 
heavily borrowed from interventions among healthy, unhealthy, overweight, and elderly 
adults [111-113, 118, 119]. With these examples, the final recommendation from this pilot 
study is that the design of interventions to improve QoL should utilize knowledge transfer to 
a much greater extent between clinical and healthy populations and between different 
clinical subpopulations. There exist far more evidence-based recommendations about how to 
encourage non-SUD populations to begin and maintain beneficial exercise than about the 
SUD population, and the SUD research and treatment fields should not hesitate in examining 
the potential usefulness of these recommendations in an attempt to provide SUD patients 
with such a promising intervention. 
Entering this project, research from the SUD field told us that patients have far lower 
QoL than a person without a SUD, and that higher QoL has an important predictive and 
possibly causal relationship with maintained treatment. From the exercise science research 
field, we knew that one of exercise’s numerous benefits is increased QoL. And from patients 
and treatment providers themselves, we heard pleas for attention to QoL within treatment 
matrices and the recovery paradigm [32, 51, 53, 165, 181, 182]. This pilot study has 
provided preliminary evidence that even small amounts of exercise in a social context can 
have statistically  and clinically significant positive impacts on SUD patients’ physical health 
QoL and psychological health QoL. That which remains now is to use these design 
recommendations and findings to continue developing impactful, sustainable exercise 
interventions for this population. 
5.2	  Research	  limita@ons
The non-experimental design utilized in this pilot study  limits my ability  to assert the 
causal effects of the exercise groups. The lack of randomization and small sample size are 
particular violations of non-spuriousness that challenge internal validity, while the inability 
to statistically  control for mental health burden, somatic health burden, and addiction 
severity require these variables to be taken into account when interpreting the study’s 
positive results. 
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The sample was comprised of urban, predominantly middle-aged persons with an 
established history  of SUD treatment and poly-substance use. The exercise groups may not 
have been accepted to the same extent or had similar effects if conducted within a different 
subpopulation of SUD patients, such as those with a lower addiction severity  or participating 
in outpatient programs.  
The dearth of in-depth qualitative data on participants’ experiences with the exercise 
groups has lent less help than anticipated in crafting future intervention recommendations, 
the procedural objective of this thesis. Analysis of the qualitative data that was collected may 
have been affected by my translations from Norwegian to English. 
5.3	  Future	  research
The positive impacts of group exercise on two out of four domains of QoL are reason 
enough to pursue further research among a population with notoriously low QoL. In terms of 
substance, this pilot study’s findings point to several areas that require further research: 
First, while the longitudinal nature of this pilot study allowed for preliminary 
mentions of causality, further follow-up data collection regarding the maintenance of QoL 
changes and QoL’s relationship  to upkeep of exercise and SUD treatment retention should be 
added to future interventions. It is important  to maintain usage of a standardized QoL tool to 
enable comparison with other chronic disease populations and other treatment interventions. 
Second, given that the exercise groups appealed to those suffering the most 
physically and mentally, it  would be interesting to explore modifications of this study’s 
design recommendations that could solidify its appeal to this subset of patients. A multi-site 
experiment that varied design factors such as dose, intensity, or group size would provide 
information about the characteristics of SUD patients who respond to different  factors. 
Qualitative research could provide deeper insight into participants’ reasons and motivations 
for participating, of which various design features may play  one of many roles. The theme of 
motivation could be an important focus in and of itself: how do participants motivate 
themselves to participate (e.g. incentives, a certain threshold of self-efficacy)?; does exercise 
motivate participants in other areas of their lives or treatment (e.g. increased health 
behaviors)?; and what are the gaps in motivation that could be addressed?.
Third, qualitative research could also help  uncover patients’ perspectives of the 
mechanisms by which group exercise affects each QoL domain, and further inform program 
design. If conducted as part of a longer study with further follow-up, such research could 
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also explore the possible intersection of exercise, QoL, and recovery, and could probe for 
mediating factors such as self-confidence and self-efficacy  that were outside the scope of 
this pilot study. 
Fourth, the practicalities and possibilities of integrating a group exercise program 
into SUD treatment should be explored. This pilot study was low-cost but labor-intensive, 
and coaches were not employees of any  participating institutions. Each subsequent, similar 
intervention implemented and evaluated will add experiential knowledge about how best to 
implement such a program. Organizations that struggle financially to provide adjunct 
therapies to SUD patients could benefit the most from further experimentation with this low-
cost intervention. 
The utility  of an exercise intervention in improving QoL also speaks to the 
importance of treating SUD patients holistically. SUD treatment can and should include 
protective and alleviatory mechanisms to address the wide range of negative effects that 
SUD has on patients, those closest to them, and their societies. An exercise intervention is 
only one of many QoL-enhancing options that should be explored for its far-reaching 
benefits.  
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World Health Organization Quality of Life Brief / WHOQOL-BREF (III) 
 
Instruksjon 
Dette spørreskjemaet spør etter hvordan du opplever din livskvalitet, helsen og andre sider ved 
livet ditt.  Vennligst besvar alle spørsmålene.  Hvis du er usikker på hvilket svaralternativ du skal 
velge, skal du velge det som synes å passe best.  Dette kan ofte være din første reaksjon på 
spørsmålet. 
Et eksempel 
Tenk på dine håp og gleder, hva du er opptatt av og hvordan du ønsker livet skal være.  Vi ber deg 
tenke på hvordan livet ditt har vært de siste to ukene.  Med hensyn til de siste to ukene, kan for 
eksempel et spørsmål være: 
 
 
Får du den type støtte 
som du trenger fra 
andre? 
 
Ikke i det 
hele tatt 
Litt Ganske 
mye 
 Mye 4 Fullstendig 
1 2 3 4 5 
 
Sett ring rundt det tallet som best svarer til hvor mye du har fått av den type støtte du trengte fra 
andre i de siste to ukene.  Du vil da sette ring rundt tallet 4 dersom du fikk mye støtte fra andre. 
 
 
Får du den type støtte 
som du trenger fra 
andre? 
 
Ikke i det 
hele tatt 
Litt Ganske 
mye 
Mye Mye 4 Fullstendig 
1 2 3 4 5 
 
 
Du vil sette ring rundt tallet 1 dersom du ikke i det hele tatt har fått den type støtte du trengte fra 
andre.   
 
 
	  Side 3 
Vennligst les hvert spørsmål, tenk over hva du føler og sett ring rundt det tallet på 
svarskalaen som for deg gir det beste svaret på hvert spørsmål. 
 
 
 
Svært 
dårlig Dårlig 
Verken god eller 
dårlig God 
Svært 
god 
Hvordan vil du vurdere 
kvaliteten på livet ditt? 
1 2 3 4 5 
 
 
 
Svært 
utilfreds Utilfreds 
Verken 
tilfreds eller 
utilfreds Tilfreds 
Svært 
tilfreds 
Hvor tilfreds er du med 
helsen din? 
1 2 3 4 5 
 
De følgende spørsmålene spør etter hvor mye du har opplevd av bestemte ting i de siste to 
ukene.  
 
 
 Ikke i det 
hele tatt Litt 
Til en 
viss grad I høy grad 
I svært 
høy grad 
I hvilken grad føler du at  
smerte hindrer deg i å gjøre det 
du må? 
1 2 3 4 5 
I hvilken grad trenger du 
medisinsk behandling for å 
kunne fungere til daglig? 
1 2 3 4 5 
Hvor mye gleder du deg over 
livet? 
1 2 3 4 5 
I hvilken grad føler du at livet 
ditt er meningsfullt? 
1 2 3 4 5 
Hvor godt kan du konsentrere 
deg? 
1 2 3 4 5 
Hvor trygg føler du deg til 
daglig? 
1 2 3 4 5 
Hvor sunne er dine fysiske 
omgivelser? 
1 2 3 4 5 
 
 
De følgende spørsmålene spør etter hvor fullstendig du opplevde eller kunne utføre 
bestemte ting i løpet av de siste to ukene.  
	  Side 4 
 
 
 Ikke i det 
hele tatt Litt 
Til en 
viss grad I høy grad Fullstendig 
Har du nok energi til dine 
daglige gjøremål? 
1 2 3 4 5 
Kan du akseptere utseende 
ditt? 
1 2 3 4 5 
Har du nok penger til å dekke 
dine behov? 
1 2 3 4 5 
Hvor tilgjengelig er den 
informasjonen som du trenger i 
dagliglivet? 
1 2 3 4 5 
I hvilken grad har du mulighet 
for å delta i fritidsaktiviteter? 
1 2 3 4 5 
 
 
Svært 
dårlig Dårlig 
Verken 
godt eller 
dårlig Godt Svært godt 
Hvor godt er du i stand til å 
komme deg dit du vil? 
1 2 3 4 5 
 
 
De følgende spørsmålene spør etter hvor glad eller  tilfreds du har følt deg over bestemte 
sider ved livet i de siste to ukene.   
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Svært 
utilfreds Utilfreds 
Verken 
tilfreds eller 
utilfreds Tilfreds 
Svært 
tilfreds 
Hvor tilfreds er du med 
hvordan du sover? 
1 2 3 4 5 
Hvor tilfreds er du med din 
evne til å utføre dine daglige 
gjøremål? 
1 2 3 4 5 
Hvor tilfreds er du med din 
arbeidskapasitet? 
1 2 3 4 5 
Hvor tilfreds er du med deg 
selv? 
1 2 3 4 5 
Hvor tilfreds er du med ditt 
forhold til andre mennesker? 
1 2 3 4 5 
Hvor tilfreds er du med ditt 
seksualliv? 
1 2 3 4 5 
Hvor tilfreds er du med den 
støtten du får fra dine venner? 
1 2 3 4 5 
Hvor tilfreds er du med 
forholdene der du bor? 
1 2 3 4 5 
Hvor tilfreds er du med din 
tilgang til helsetjenester? 
1 2 3 4 5 
Hvor tilfreds er du med 
transportmulighetene dine? 
1 2 3 4 5 
 
 
Det følgende spørsmålet refererer seg til hvor ofte du har opplevd eller følt negative følelser 
i løpet av de siste to ukene.  
 
 
 Aldri Sjelden Ofte Svært 
ofte 
Alltid 
Hvor ofte opplever du 
negative følelser, som f.eks. 
at du er trist, fortvilet, 
engstelig eller deprimert? 
1 2 3 4 5 
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  Kjønn 
	  
  Dato for start kartlegging 
	  
  Dato for første behandlingsdag 
   (for LAR-pasienter første dag med LAR medisin) 
 
  Behov for tolk 
	  
  Fødeland og etnisk bakgrunn 
	  
  Sivilstatus 
	  
  Høyeste fullførte utdanning 
 
  Yrkesstatus 
	  
  Viktigste inntekt siste 4 uker 
	  
  Bor sammen med 
  (flere valg mulig) 
	  
  Boligforhold siste 4 uk 
	  
  Hatt en stabil bosituasjon siste 4 uker 
	  
	  dag                måned                             år 
 
1 = Ja 
2 = Nei 
1 = Norge 
2 = Norden utenom Norge 
3 = Vest-Euroopa utenom Norden 
4 = Øst-Europa 
5 = Asia (inkl. Tyrkia) 
6 = Afrika 
7= Sør- og Mellom-Amerika 
(ink.l Mexico) 
8 = Nord-Amerika 
9 = Oceania 
99 = Ukjent 
Fødeland              Mors fødeland             Fars fødeland 
0 = Ikke oppgitt 
1 = Aldri gift 
2 = Gift 
3 = Enke / enkemann 
4 = Separert 
5 = Skilt 
6 = Registrert partner 
7 = Separert partner 
8 = Skilt partner 
9 = Gjenlevende partner 
1 = Ikke avsluttet grunnskole 
2 = Grunnskole 
3 = Videregående skole/gymnas/yrkesskoleutdanninger 
4 = Faglig yrkesutdanning 
5 = Treårig høyskole/universitet 
6 = Mer enn treårig høyskole/universitet 
9 = Ukjent 
1 = Mann 
2 = Kvinne 
	  dag                måned                             år 
1 = Utenfor arbeidsmarkedet og ikke under utdanning 
2 = Heltidsjobb 
3 = Deltidsjobb 
4 = Under utdanning 
5 = Deltidsjobb og under utdanning 
9 = Ukjent 
1 = Lønnet arbeid 
2 = Forsørget 
3 = Arbeidsledighetstrygd 
4 = Syke-/rehabiliteringspenger 
5 = Atføringspenger 
6 = Uførepensjon 
7 = Alderspensjon 
8 = Sosial stønad 
9 = Annet 
10 = Ukjent 
11 = Studielån/stipend 
12 = Stønad til enslig forsørger 
1 = Bor alene 
2 = Bor i parforhold 
3 = Bor sammen med venner 
4 = Bor sammen med foreldre 
5 = Bor sammen med barn under 18 år 
6 = Bor sammen med barn over 18 år 
7 = Bor sammen med andre 
9 = Ukjent 
1 = Ingen bolig 
2 = Hospits/hybelhus/hotell 
3 = Institusjon 
4 = Egen privat bolig 
5 = Privat bolig eid av annen 
6 = Annet 
1 = Ja 
2 = Nei 
9 = Ukjent 
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  Barn 
  Antall egne barn uansett alder og bosituasjon   
  Alder og bosituasjon for barn under 18 år  
 0-6 år 7-12 
år 
13-17 
år 
  Hjemmeboende barn (egne), angi antall    
  Hjemmeboende barn (andres), angi antall    
 
  Tiltak for barn under 18 år (ikke NPR) 
 
1 
= 
 Ik
ke
 b
eh
ov
 
2 
= 
 B
ør
 iv
er
ks
et
te
s 
3 
 =
 E
r i
ve
rk
sa
tt 
9 
= 
U
kj
en
t 
 
  Hjemmeboende barn (egne), angi antall 
 
    
 
  Hjemmeboende barn (andres), angi antall 
 
    
  Graviditet 
 
 
1 = Ja 
2 = Nei 
9 = Ukjent 
 
  
Antall uker gravid 
(Eks.: 1 uke = 01; 2 uker = 02; 10 uker = 10) 
    
  Vedvarende somatiske sykdommer eller skader 
 
  
1 = Ja 
2 = Nei 
9 = Ukjent 
 
  Psykiske vansker/lidelser 
 
Siste 4 
uker 
 
Tidligere 
i livet 
 
 
(begge kolonnene må besvares for hvert spørsmål) 
1 = Ja             2 = Nei          9 = Ukjent 
   
Hatt alvorlige depresjoner 
 
   
Hatt alvorlig angst 
 
   
Hatt vrangforestillinger/hallusinasjoner 
 
   
Blitt forskrevet medisiner for et eller annet 
psykisk/følelsesmessig problem 
 
   
Hatt alvorlige tanker om å ta livet av seg 
 
 
	  
  Type tidligere behandling rus 
 
 
1 = Kun avrusning (institusjon eller poliklinisk) 
2 = Poliklinisk vedlikeholdsrehabilitering (LAR) 
3 = Annen poliklinisk behandling, inkludert 
dagtilbud 
4 = Døgnbehandling ut over avrusning 
5 = Poliklinisk-(LAR eller annen) og 
døgnbehandling (inkludert avrusning) 
6 = Behandling utenfor rusinstitusjon/rustiltak 
8 = Ikke tidligere behandlet 
9 = Ukjent 
 
  Tid siden siste behandling rus 
 Angi antall måneder siden siste behandling (Eks.: 1 mnd = 001; 12 mndr = 012; 12 år = 144)  000 = Vært i behandling, men ukjent når sist 
  Antall rusmidler brukt siste 6 måneder 
 
 
Angi antall rusmidler 
(Eks.: 1 rusmiddel = 01; 2 rusmidler = 02;  
10 rusmidler = 10) 
 
00 = Ingen 
99 = Ukjent 
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Rusmiddel-/medikamentprofil siste 2 måneder 
 
  
Type rusmiddel/medikament 
(Bruk koden nedenfor) 
 
Inntaksmåte  
(Bruk koden nedenfor) 
 
Hvor ofte brukt siste 
4 uker  
(Bruk koden nedenfor) 
 
Alder brukt første 
gang  
 
Hvor lenge 
problemfylt bruk 
(Antall år) 
 Mest brukte 
 rusmiddel/ 
 medikament 
     
 2. mest brukte 
     
 3. mest brukte 
     
 4. meste brukte 
     
 
 0 = Ingen 
 1 = Alkohol 
 2 = Cannabis 
 3 = Heroin/Opium 
 4 = Metadon, buprenorfin, 
       andre opiater/opioder 
       forskrevet i LAR- 
       program 
 5 = Metadon, buprenorfin, 
       andre opiater/opioder 
       forskrevet utenfor  
       LAR-program 
 6 = Metadon, buprenorfin, 
       andre opiater/opioder 
       ervervet uten at  
       forskrevet av lege 
 7 = Benzodiazepiner  
       forskrevet av lege 
 
8 = Benzodiazepiner ikke  
      forskrevet av lege 
9 = Andre vanedannende 
      medikamenter 
10 = Amfetamin 
11 = Kokain 
12 = Crack 
13 = Andre 
        sentralstimulerende 
        midler 
14 = LSD og likn. 
15 = Ecstasy 
16 = Løsemidler 
17 = Rødsprit o.l 
18 = Annet 
99 = Ukjent 
 
 
 1 = Drikker/spiser 
 2 = Injiserer 
 3 = Røyker 
 4 = Sniffer 
 8 = Annet 
 9 = Ukjent 
 
 1 = Ikke brukt 
 2 = Sjeldnere enn 1 
       gang i uken 
 3 = Omtrent ukentlig 
 4 = 2-4 dager i uken 
 5 = 5-6 dager i uken 
 6 = Daglig 
 9 = Ukjent 
 
 99 = Ukjent 
 
 00 = Ikke 
 01 = Et år eller mindre 
 99 = Ukjent 
Brukt sprøyter før?  Antall ganger overdose hele livet 
  
1 = Ja 
2 = Nei 
9 = Ukjent 
 
  
Alder første sprøytebruk  
  
 
Angi alder i år 
 
00 = Aldri brukt sprøyter 
99 = Ukjent 
 
 
 
Sprøytebruk siste 4 uker   Opplysninger fra usikker kilde? 
  
1 = Ikke brukt sprøyte 
2 = Sjeldnere enn 1 gang i uken 
3 = Omtrent ukentlig 
4 = 2-4 dager i uken 
5 = Daglig eller nesten daglig 
9 = Ukjent 
 
  
1 = Ja 
2 = Nei 
 
Antall for hvert av stoffområdene 
 
 
 
 
Alkohol 
 
 
 
 
Narkotika 
 
 
 
 
 
Medikament 
 
 
 
 
 
Kombinasjon 
 
00 = Ingen ganger 
99 = Ukjent 
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Behandlingserfaring 
 
Hvor mange måneder til sammen har du vært i døgnbehandling i ditt liv? 
(Eks.: 1 mnd = 001; 12 mndr = 012; 12 år = 144) 
 
 
Hvor mange måneder til sammen har du vært i poliklinisk behandling i ditt liv? 
(Eks.: 1 mnd = 001; 12 mndr = 012; 12 år = 144) 
 
 
Hva er ditt behandlingsmål med dette behandlingsopplegget? 
 
1 = Rehabilitering med rusfrihet 
2 = Stabilisering med bedre rusmestring 
 
 
Ønske for varighet av behandling?  
(Eks.: 1 mnd = 001; 12 mndr = 012; 12 år = 144, Livslang = 999) 
 
 
 
Kontrollert miljø 
 
I løpet av de siste 30 dagene før denne behandlingen, 
har du vært innlagt i det vi kan kalle et «kontrollert miljø»? 
 
 
1 = Nei 
2 = Fengsel 
3 = Behandlingsinstitusjon for rusmiddelmisbrukere 
4 = Somatisk sykehus 
5 = Psykiatrisk sykehus/klinikk 
6 = Bare avrusning/avgiftning 
7 = Annet kontrollert miljø, spesifiser: ……………………………………. 
Var dette miljøet/behandling med LAR? □ Nei 
□ Ja 
 
Tobakksvaner siste 6 måneder før behandling 
 
Røyket du tobakk? 
 
Brukte du snus? 
  
1 = Ja 
2 = Nei 
 
  
1 = Ja 
2 = Nei 
 
 
Hvis ja, hvor mange sigaretter daglig?    
 
 
Hvis ja, antall bokser per dag? 
 
 
 
 
	   
SCL – 25. Hvor mye har du vært plaget av: (den siste uka) 
(samme spørsmål i SCL-90) 
 
 
Sett en ring rundt det svaret som passer deg best. 
0 
 
Ikke i det 
hele tatt 
 
1 
 
Litt 
2 
 
Moderat 
3 
 
Ganske 
mye 
4 
 
Veldig 
mye 
1. Hodepine 0 1 2 3 4 
2. Skjelving 0 1 2 3 4 
3. Matthet eller svimmelhet 0 1 2 3 4 
4. Nervøsitet, indre uro 0 1 2 3 4 
5. Plutselig frykt uten grunn 0 1 2 3 4 
6. Stadig redd eller engstelig 0 1 2 3 4 
7. Hjertebank, hjerteslag som løper avgårde 0 1 2 3 4 
8. Følelse av å være anspent, oppjaget 0 1 2 3 4 
9. Anfall av angst eller panikk 0 1 2 3 4 
10. Så rastløs at det er vanskelig å sitte stille 0 1 2 3 4 
11. Mangel på energi, alt går langsommere enn vanlig 0 1 2 3 4 
12. Lett for å klandre seg selv 0 1 2 3 4 
13. Lett for å gråte 0 1 2 3 4 
14. Tanker om å ta ditt liv 0 1 2 3 4 
15. Dårlig matlyst 0 1 2 3 4 
16. Søvnproblemer 0 1 2 3 4 
17. Følelse av håpløshet med tanke på fremtiden 0 1 2 3 4 
18. Nedtrykt, tungsindig 0 1 2 3 4 
19. Følelse av ensomhet 0 1 2 3 4 
20. Tap av seksuell lyst og interesse 0 1 2 3 4 
21. Følelse av å være lurt i en felle eller fanget 0 1 2 3 4 
22. Mye bekymret eller urolig 0 1 2 3 4 
23. Uten interesse for noe 0 1 2 3 4 
24. Følelse av at alt er et slit 0 1 2 3 4 
	   
25. Følelse av å være unyttig 0 1 2 3 4 
	  
Somatisk helse. Hvor mye har du vært plaget av: (siste 2 måneder) 
 
Sett en ring rundt det svaret  
som passer deg best. 
0 
 
Ikke i det 
hele tatt 
 
1 
 
Litt 
2 
 
Moderat 
3 
 
Ganske 
mye 
4 
 
Veldig 
mye 
Kronisk lidelse? 
 
(minst 3 mnd i løpet av 
siste halvår før inntak) 
Ja Nei 
Fordøyelsesplager 0 1 2 3 4 □ □ 
Diare 0 1 2 3 4 □ □ 
Forstoppelse 0 1 2 3 4 □ □ 
Luftveisplager 0 1 2 3 4 □ □ 
Eksem 0 1 2 3 4 □ □ 
Hudinfeksjoner 0 1 2 3 4 □ □ 
Leddsmerter 0 1 2 3 4 □ □ 
Hodepine 0 1 2 3 4 □ □ 
Brystsmerter 0 1 2 3 4 □ □ 
Svimmelhet 0 1 2 3 4 □ □ 
Nedsatt hukommelse 0 1 2 3 4 □ □ 
Synsforstyrrelser 0 1 2 3 4 □ □ 
Urinveisplager 0 1 2 3 4 □ □ 
Kjønnsykdommer 0 1 2 3 4 □ □ 
Blodpropp 0 1 2 3 4 □ □ 
Tann/tannkjøttsplager 0 1 2 3 4 □ □ 
	  
Har du noen av de nevnte sykdommer per i dag? 
 
 Ja Nei 
 
Ukjent/ 
vet ikke 
 
Hvis Ja, har du i løpet av de siste 6 mnd fått 
behandling for din(e) sykdom(mer)? 
    Ja Nei 
Diabetes □ □ □ □ □ 
Høyt blodtrykk □ □ □ □ □ 
Hjertesykdom □ □ □ □ □ 
KOLS □ □ □ □ □ 
Astma □ □ □ □ □ 
Hepatitt B □ □ □ □ □ 
	   
Hepatitt C □ □ □ □ □ 
Leverchirrose □ □ □ □ □ 
HIV □ □ □ □ □ 
Kreft □ □ □ □ □ 
Annet 
…………………………….. □ □ □ □ □ 
	  
 
Dopingmidler siste 6 måneder før behandling 
 
Brukte du dopingmidler?  
1 = Ja 
2 = Nei 
 
 
Hvis ja, hvor mange ganger per uke?    
 
Hvis ja, hvilken type dopingmidler?          □ Anabole steroider               □ Andre: ……………………………. 
 
Fysisk trening siste 6 måneder før behandling 
 Drev du med fysisk trening, enten organisert eller i privat regi?   
1 = Ja 
2 = Nei 
 
Hvis ja, hva slags trening? …………………………………………………………… 
 
Hvis ja, hvor mange minutter per dag?                        Hvor mange dager per uke?    
 
Høyde og vekt 
 
Selvrapportert vekt i kilo 
 
 
Selvrapportert høyde i cm 
 
 
Hvordan vurderer du din egen vekt i dag?                       □ For lav            □ Passe            □ For høy 
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Rusmiddel-/medikamentprofil siste 2 måneder 
 
  
Type rusmiddel/medikament 
(Bruk koden nedenfor) 
 
Inntaksmåte  
(Bruk koden nedenfor) 
 
Hvor ofte brukt siste 
4 uker  
(Bruk koden nedenfor) 
 
Alder brukt første 
gang  
 
Hvor lenge 
problemfylt bruk 
(Antall år) 
 Mest brukte 
 rusmiddel/ 
 medikament 
     
 2. mest brukte 
     
 3. mest brukte 
     
 4. meste brukte 
     
 
 0 = Ingen 
 1 = Alkohol 
 2 = Cannabis 
 3 = Heroin/Opium 
 4 = Metadon, buprenorfin, 
       andre opiater/opioder 
       forskrevet i LAR- 
       program 
 5 = Metadon, buprenorfin, 
       andre opiater/opioder 
       forskrevet utenfor  
       LAR-program 
 6 = Metadon, buprenorfin, 
       andre opiater/opioder 
       ervervet uten at  
       forskrevet av lege 
 7 = Benzodiazepiner  
       forskrevet av lege 
 
8 = Benzodiazepiner ikke  
      forskrevet av lege 
9 = Andre vanedannende 
      medikamenter 
10 = Amfetamin 
11 = Kokain 
12 = Crack 
13 = Andre 
        sentralstimulerende 
        midler 
14 = LSD og likn. 
15 = Ecstasy 
16 = Løsemidler 
17 = Rødsprit o.l 
18 = Annet 
99 = Ukjent 
 
 1 = Drikker/spiser 
 2 = Injiserer 
 3 = Røyker 
 4 = Sniffer 
 8 = Annet 
 9 = Ukjent 
 
 1 = Ikke brukt 
 2 = Sjeldnere enn 1 
       gang i uken 
 3 = Omtrent ukentlig 
 4 = 2-4 dager i uken 
 5 = 5-6 dager i uken 
 6 = Daglig 
 9 = Ukjent 
 
 99 = Ukjent 
 
 00 = Ikke 
 01 = Et år eller mindre 
 99 = Ukjent 
	  
Brukt sprøyter før? 
  
1 = Ja 
2 = Nei 
9 = Ukjent 
 
Alder første sprøytebruk 
  
 
Angi alder i år 
 
00 = Aldri brukt sprøyter 
99 = Ukjent 
 
 
Sprøytebruk siste 4 uker  
  
1 = Ikke brukt sprøyte 
2 = Sjeldnere enn 1 gang i uken 
3 = Omtrent ukentlig 
4 = 2-4 dager i uken 
5 = Daglig eller nesten daglig 
9 = Ukjent 
 
Side 3 
	  
 
 
Tobakksvaner siste 2 måneder 
 
Røyket du tobakk? 
 
Brukte du snus? 
  
1 = Ja 
2 = Nei 
 
  
1 = Ja 
2 = Nei 
 
 
Hvis ja, hvor mange sigaretter daglig?    
 
 
Hvis ja, antall bokser per dag? 
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SCL – 25. Hvor mye har du vært plaget av: (den siste uka) 
(samme spørsmål i SCL-90) 
 
 
Sett en ring rundt det svaret som passer deg best. 
0 
 
Ikke i det 
hele tatt 
 
1 
 
Litt 
2 
 
Moderat 
3 
 
Ganske 
mye 
4 
 
Veldig 
mye 
1. Hodepine 0 1 2 3 4 
2. Skjelving 0 1 2 3 4 
3. Matthet eller svimmelhet 0 1 2 3 4 
4. Nervøsitet, indre uro 0 1 2 3 4 
5. Plutselig frykt uten grunn 0 1 2 3 4 
6. Stadig redd eller engstelig 0 1 2 3 4 
7. Hjertebank, hjerteslag som løper avgårde 0 1 2 3 4 
8. Følelse av å være anspent, oppjaget 0 1 2 3 4 
9. Anfall av angst eller panikk 0 1 2 3 4 
10. Så rastløs at det er vanskelig å sitte stille 0 1 2 3 4 
11. Mangel på energi, alt går langsommere enn vanlig 0 1 2 3 4 
12. Lett for å klandre seg selv 0 1 2 3 4 
13. Lett for å gråte 0 1 2 3 4 
14. Tanker om å ta ditt liv 0 1 2 3 4 
15. Dårlig matlyst 0 1 2 3 4 
16. Søvnproblemer 0 1 2 3 4 
17. Følelse av håpløshet med tanke på fremtiden 0 1 2 3 4 
18. Nedtrykt, tungsindig 0 1 2 3 4 
19. Følelse av ensomhet 0 1 2 3 4 
20. Tap av seksuell lyst og interesse 0 1 2 3 4 
21. Følelse av å være lurt i en felle eller fanget 0 1 2 3 4 
22. Mye bekymret eller urolig 0 1 2 3 4 
23. Uten interesse for noe 0 1 2 3 4 
24. Følelse av at alt er et slit 0 1 2 3 4 
25. Følelse av å være unyttig 0 1 2 3 4 
	  
Somatisk helse. Hvor mye har du vært plaget av: (siste 6 måneder) 
 
Sett en ring rundt det svaret  
som passer deg best. 
0 
 
Ikke i det 
hele tatt 
 
1 
 
Litt 
2 
 
Moderat 
3 
 
Ganske 
mye 
4 
 
Veldig 
mye 
Kronisk lidelse? 
 
(minst 3 mnd i løpet av 
siste halvår før inntak) 
Ja Nei 
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Fordøyelsesplager 0 1 2 3 4 □ □ 
Diare 0 1 2 3 4 □ □ 
Forstoppelse 0 1 2 3 4 □ □ 
Luftveisplager 0 1 2 3 4 □ □ 
Eksem 0 1 2 3 4 □ □ 
Hudinfeksjoner 0 1 2 3 4 □ □ 
Leddsmerter 0 1 2 3 4 □ □ 
Hodepine 0 1 2 3 4 □ □ 
Brystsmerter 0 1 2 3 4 □ □ 
Svimmelhet 0 1 2 3 4 □ □ 
Nedsatt hukommelse 0 1 2 3 4 □ □ 
Synsforstyrrelser 0 1 2 3 4 □ □ 
Urinveisplager 0 1 2 3 4 □ □ 
Kjønnsykdommer 0 1 2 3 4 □ □ 
Blodpropp 0 1 2 3 4 □ □ 
Tann/tannkjøttsplager 0 1 2 3 4 □ □ 
	  
 
Dopingmidler siste 2 måneder 
 
Brukte du dopingmidler?  
1 = Ja 
2 = Nei 
 
 
Hvis ja, hvor mange ganger per uke?    
 
Hvis ja, hvilken type dopingmidler?          □ Anabole steroider               □ Andre: 
……………………………. 
 
Fysisk trening siste 2 måneder 
 Skal du fortsette å drive med fysisk trening?   
1 = Ja      3 = Vet 
ikke 
2 = Nei 
 
 
Hvis ja, hva slags trening? …………………………………………………………… 
 
Hvis ja, hvor mange minutter per dag?                        Hvor mange dager per uke?    
Hvordan kan du beskrive din erfaring med vår treningsgruppe? Tenk om din fysisk erfaring, 
kommunikasjon med din trainer og andre deltakere, hvor og når din gruppe møtet opp, o.s.v.  
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
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…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
 
Hva kan gjøres forskellig eller bedre? Hva synes du ikke var bra? 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
Hva var bra gjennomført? Hva likter du spesiel godt?  
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………………… 
 
 
Høyde og vekt 
 
Selvrapportert vekt i kilo 
 
 
Selvrapportert høyde i cm 
 
 
Hvordan vurderer du din egen vekt i dag?               □ For lav            □ Passe            □ For høy 
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Forespørsel om deltakelse i forskningsprosjektet 
 ”Fysisk aktivitet for å øke livskvalitet blant ruspasienter”  
  
Bakgrunn og hensikt 
Dette er en forespørsel til deg om å delta i en forskningsstudie som inkluderer et treningsprogram eller 
som deltager i sammenligningsgruppen uten treningsprogram. Prosjektet skal undersøke om det er en 
sammenheng mellom fysisk trening og deltakernes livskvalitet. Du inviteres til å delta i denne studien 
fordi du nå er/har vært under behandling for rusmisbruk eller har et rusmisbruksproblem. Denne 
studien vil inngå i masteroppgaven til Ley Muller ved Høgskolen i Oslo, som er veiledet av professor 
Thomas Clausen ved Senter for rus- og avhengighetsforskning (SERAF). 
 
Hva innebærer studien? 
Deltagelse i sammenligningsgruppen innebærer at du må fylle ut noen spørreskjema angående ditt 
rusmiddelbruk, fysisk og psykisk helse og livskvalitet. 
Deltakelse i treningsgruppen vil innebære et 10 ukers treningsprogram, med lett fysisk aktivitet i 30 
minutter 3 ganger i uken. Treningene vil foregå i gruppe og vil bli ledet av en trener. I tillegg til 
deltagelse i treningsprogrammet, vil vi både før oppstart og etter endt 10-ukers program samle inn 
noen data ved hjelp av spørreskjema som vi ber deg fylle ut. Spørreskjemaet inkluderer spørsmål 
angående ditt rusmiddelbruk, fysisk og psykisk helse, og livskvalitet. Det vil også etter hver 
treningsøkt være mulig å mer uformelt fortelle treneren hvordan treningsøkten var, disse opplevelsene 
vil bli notert av treneren og informasjonen vil inngå i datamaterialet. Du kan også bli bedt om å delta i 
en fokusgruppe innen én måned etter at programmet er avsluttet. Tema for diskusjon i fokusgruppene 
vil være; hva som var bra og hva som kan forbedres ved treningsprogrammet og opplevelsen av 
trening som del av rusbehandlingen. Dataene fra denne studien vil brukes for å undersøke om en 
tidsbegrenset treningsintervensjon kan påvirke livskvaliteten til pasienter i rusbehandling. 
 
Mulige fordeler og ulemper 
Det forventes ingen konkrete ulemper med lavterskel trening, men noen vil kanskje oppleve 
muskelstølhet etter treningene. Støle muskler etter trening er ufarlig. Det er alltid en viss mulighet for 
uforutsette helsemessige komplikasjoner i tilknytning til utøvelse av fysisk aktivitet, men trening i 
moderat tempo i 30 minutter ansees å være en del av normalaktivitet som ikke innebærer nevneverdig 
øket risiko for sykdom eller skade. I forbindelse med inklusjon til studien vil vi stille noen spørsmål 
om helsen din for å forsøke å identifisere de som evt har en helsetilstand som tilsier at de ikke bør 
være med i studien.  
 
Deltagelse i studien inkluderer fysisk aktivitet. Fysisk aktivitet kan bidra til forbedret kardiovaskulær 
helse, utholdenhet, styrke og fleksibilitet. Deltagelse i dette prosjektet, som inkluderer gruppebasert 
fysisk aktivitet, vil gi deg som deltager mulighet til å samhandle og dele opplevelser med andre 
deltakere og frivillige. Treningsprogrammet vil kunne oppleves som en pause fra den daglige rutinen. 
Til syvende og sist, forfatterens hypotese er at din generelle livskvalitet - målt som samlet kvalitet av 
dine sosiale relasjoner og miljø så vel som din fysiske og psykiske helse - vil kunne øke som et resultat 
av din deltagelse i treningsprogrammet. 
  
Hva skjer med informasjonen om deg?  
Prosjektet vil samle inn informasjon om deg og din helse, sammen med ditt navn og fødselsdato. Dette 
fordi vi skal kunne følge opp og koble sammen svarene du gir ved oppstart og avslutning av studien. 
Det er kun personell knyttet til prosjektet som har adgang til navnelisten. 
  
Dataanalyser på sammenkoblede data etter endt inklusjonsperiode vil foregå i en datafil som bare 
inneholder et løpenummer og filen vil således være uten personidentifiserbare data. Løpenummeret vil 
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kun kunne kobles til persondata via en separat kodenøkkelfil. Kodenøkkelen vil slettes ved prosjektets 
slutt. 
Ingen enkeltpersoner vil kunne identifiseres i materialet som inkluderes og publiseres fra prosjektet. 
  
Frivillig deltakelse 
Deltakelse i undersøkelsen er frivillig. Du kan trekke deg fra studien når som helst og uten å oppgi 
noen spesiell grunn. Dette vil ikke ha noen konsekvenser for din videre behandling. Hvis du ønsker å 
delta, må du undertegne samtykkeerklæringen på siste side. Hvis du senere ønsker å trekke tilbake ditt 
samtykke eller har spørsmål til studien, kan du kontakte Ley Muller på tlf: 4547 1880. 
   
Ytterligere informasjon om studien finnes i kapittel A – utdypende forklaring av hva studien 
innebærer. 
 
Ytterligere informasjon om personvern finnes i kapittel B – Personvern. 
  
Samtykkeerklæring følger etter kapittel B. 
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Kapittel A- utdypende forklaring av hva studien innebærer 
 
Kriterier for deltakelse:  
Alle pasienter eller beboere på deltakende studiesteder vil bli invitert til å delta i studien. Alle som 
ønsker å delta vil bli bedt om å fylle ut inklusjonsskjema. For å være velgbar for deltagelse må 
følgende kriterier være oppfylt: a) alder mellom 18-65 år, b) selvrapportert stillesittende livsstil, f. eks. 
har trent mindre enn 20 minutter om dagen, i løpet av de siste seks måneder, c) har søkt seg til 
rusbehandling, d) evne til å gi informert samtykke. Deltagerne er de som allerede er i behandling, men 
som ikke har vært i organisert trening som del av behandlingen.  
 
Bakgrunnsinformasjon om studien:  
Denne pilotstudien ønsker å måle om ruspasienter opplever noen endringer i generell livskvalitet etter 
tilleggsbehandling av regelmessig fysisk aktivitet, og i så fall hvilke funksjonsområder (livskvalitet 
domener) som påvirkes mest. Intervensjonen vil engasjere inntil tretti deltakere i innendørs eller 
utendørs gåing eller jogging i tretti minutter, tre ganger i uken, i ti uker, under ledelse av en gruppe 
trener. Deltakerne vil trene sammen (med medpasienter og trener) der det er mulig. Innsamling 
«baseline» livskvalitetsdata vil være nyttig i seg selv, og vil bidra til økt kunnskap om rusmisbrukeres 
livskvalitet. Forventningen er at livskvalitet blant ruspasientene er lav ved inklusjonen også 
sammenlignet med andre pasientgrupper. Studien vil forsøke å rekruttere en kontrollgruppe blant 
pasienter i de samme institusjonene som intervensjonspasientene, som også er kjennetegnet ved lav 
fysisk aktivitet og som ikke ønsker å delta i det 10 ukers lange treningsprogrammet. Kvalitativ 
kunnskap fra fokusgruppene vil kunne belyse faktorer som kjennetegner de som fullførte versus de 
som ikke fullførte studien. Denne kunnskapen vil benyttes for å forbedre et eventuelt fremtidig design 
på en større intervensjonsstudie. 
  
Pasienter / beboere vil ikke motta ytterligere eller alternative prosedyrer eller behandling dersom de 
velger å ikke delta i denne studien. 
 
Tidsskjema:  
Rekruttering av intervensjonssteder pågår våren 2013 og vil være avsluttet i juli, 2013. Planlagt 
oppstart av intervensjonen i deltagende institusjoner er  juli/august 2013. Intervensjoner på hvert 
behandlingssted kan skje på rullerende basis (og nye deltakere kan legges til en gruppe som allerede er 
i gang), men alle må være fullført innen utgangen av desember 2013. Inklusjonsdata samles inn før 
første trening, og oppfølgingsdata etter siste treningsøkt etter 10 uker. Fokusgrupper vil være 
organisert innen en måned etter hvert intervensjonssteds siste trening. 
 
Mulige fordeler:  
Selvom dette treningsprogrammet er av lav intensitet, forventes en viss helsemessige gevinst som 
generell redusert risiko for hjerte-og karsykdommer, mens redusert hypertensjon ikke er forventet. 
Imidlertid er de kortsiktige fordelene knyttet til deltagelse i studien potensielt forbedret fysisk styrke, 
fleksibilitet og utholdenhet, redusert stressnivå, økt sosial støtte gjennom frivillig deltaker 
samhandlinger og økt søvnkvalitet og mengde. De generelle livskvalitetsdomener som omhandler 
fysisk helse, psykisk helse, sosiale relasjoner og miljø kan også bli forbedret. 
 
Mulige ubehag/ulemper:  
All trening innebærer en viss risiko for skade, og lav-intensitet trening er ikke noe unntak. I tillegg til å 
forverre en kjent eller ukjent tidligere tilstand, eksponerer dette programmet deltakerne for en viss 
risiko som alle turgåere eller løpere står overfor når du trener ute, som for eksempel vridning av en 
ankel eller snubling og fall. 
 
Pasientens/studiedeltakerens ansvar:  
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Treningsprogram vil bli gjort så enkelt som mulig for deltakerne, som vil motta en SMS før hver økt, 
og vil møte på avtalte lett tilgjengelige steder. Deltakerne forventes å møte opp forberedt for hver økt i 
passende klær/sko. Utfylling av spørreskjemaer før og etter endt treningsprogram vil være nødvendig. 
 
Studiedeltakeren bes opplyse til Ley Muller om mulige årsaker/situasjoner som gjør at deres deltagelse 
i studien evt ble avsluttet tidligere enn planlagt. 
  
  
Kapittel B - Personvern, biobank, økonomi og forsikring 
  
Personvern 
Opplysninger som registreres om deg er a) data du gir via screening og oppfølgingsskjemaer om din 
fysiske og mentale helse, rusmiddelbruk, og nåværende historie, og b) en livskvalitets vurdering. 
SERAF ved forskningsdirektør; Professor Thomas Clausen er databehandlingsansvarlig. 
  
Utlevering av materiale og opplysninger til andre 
Data skal ikke utleveres til andre institusjoner enn SERAF, og de navngitte forskerne i prosjektet.  
   
Rett til innsyn og sletting av opplysninger om deg 
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om 
deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du 
trekker deg fra studien, kan du kreve å få slettet innsamlede prøver og opplysninger, med mindre 
opplysningene allerede er inngått i analyser eller brukt i vitenskapelige publikasjoner.  
  
Informasjon om utfallet av studien 
Deltakerne har rett til å få informasjon om utfallet/resultatet av studien, når studien er avsluttet og 
masteroppgaven har blitt skrevet og sendt til Høgskolen i Oslo. Interesserte deltakere bes kontakte Ley 
Muller på tlf: 4547 1880. 
  
 
 
Samtykke til deltakelse i studie 
 
Deltagelse i studiens aktivitetsprogram 
Deltagelse som sammenligningsgruppe, uten aktivitetsprogram  
  
Jeg forstår at min deltakelse i denne studiens fysiske aktivitetsprogram gjennomføres på eget ansvar. 
  
Jeg er villig til å delta i studien  
  
---------------------------------------------------------------------------------------------------------------- 
(Signert av prosjektdeltaker, dato) 
  
  
Jeg bekrefter å ha gitt informasjon om studien 
  
---------------------------------------------------------------------------------------------------------------- 
(Signert, rolle i studien, dato) 
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2013/1036  Fysisk trening for å øke livskvalitet blant ruspasienter
 Senter for Rus og Avhengighetsforskning - SERAFForskningsansvarlig:
 Thomas ClausenProsjektleder:
Vi viser til tilbakemelding vedrørende ovennevnte forskningsprosjekt. Tilbakemeldingen er vurdert av
komiteens leder på delegert fullmakt.
Prosjektomtale
Studien har til hensikt å måle om ruspasienter eller tidligere ruspasienter med "substance use disorders",
eller “SUD” opplever noen endringer i sin generelle livskvalitet etter et 10-ukers program med fysisk
aktivitet i grupper, og i så fall hvilke funksjonsområder som er mest påvirket. Det skal gjøres registreringer
ved oppstart og ved oppfølging etter 10 uker med fysisk aktivitet. Intervensjonen innebærer fysisk aktivitet
30 min 3 ganger pr.uke. Datainnsamlingen omfatter variabler i to spørreskjemaer som er vedlagt. Det skal
samles inn demografiske data, samt somatiske og psykiske helseopplysninger. I alt 60 pasienter eller
beboere på deltakende studiesteder vil bli invitert til å delta i studien. Informantene fordeles etter gitte
kriterier i 2 grupper à 30 personer.
Saksgang
Komiteen behandlet saken første gang i sitt møte den 12.06.2013. I sitt brev datert 28.06.2013, utsatte
komiteen endelig vedtak i påvente av prosjektleders tilbakemelding på to punkter:
1. I informasjonsskrivet sto det at avidentifiserte livskvalitetsopplysninger ville utleveres til Diakanova
Høgskolen i Oslo. Komiteen ba om en begrunnelse for dette, i og med at det ikke fremgikk av søknaden
hvordan Diakanova Høgskolen var knyttet til prosjektet.
2. Komiteen skrev at informasjonsskrivet var utformet på en slik måte at det kan virke overtalende på de
som forespørres om deltagelse. Komiteen ba om at informasjonsskrivet ble revidert slik at det fremstår som
nøytralt ovenfor deltagerne.
Prosjektleder sendte inn sin tilbakemelding den 10.07.2013. Når det gjelder punkt 1), skriver prosjektleder at
avidentifiserte livskvalitetsopplysninger ikke skal utleveres til Diakanova Høgskolen i Oslo. Når det gjelder
punkt 2), har prosjektleder utarbeidet et revidert informasjonsskriv.
Komiteens vurdering
Komiteen tar til orientering at man ikke lenger planlegger å utlevere opplysninger til Diakanova Høgskolen i
Oslo.
Komiteen anser at endringene i informasjonsskrivet er tilfredsstillende.
Komiteen har imidlertid notert seg at i sin nåværende form henvender informasjonsskrivet seg bare til de
deltagerne som ønsker å ta del i treningsopplegget. Imidlertid skriver prosjektleder i søknaden at alle
pasienter/beboere inviteres til å delta, også de som ikke ønsker å ta del i den fysiske aktiviteten. Disse vil da
utgjøre en kontrollgruppe.  Komiteen anbefaler at informasjonsskrivet revideres slik at det kommer bedre
frem at at man kan delta i prosjektet uten å delta i den fysiske aktiviteten, og at det under overskriften
”Samtykke til deltakelse i studien” er to separate ”bokser”, slik at man kan presisere om man samtykker til
deltagelse i behandlingsgruppen eller i sammenligningsgruppen. Komiteen beklager at den ikke gjorde
oppmerksom på dette i sitt forrige brev. Komiteen ber om at et eventuelt revidert informasjonsskriv sendes
komiteen til orientering.
Vedtak
Komiteen godkjenner prosjektet i henhold til helseforskningsloven § 9 og § 33.
Godkjenningen er gitt under forutsetning av at prosjektet gjennomføres slik det er beskrevet i søknaden og i
tilbakemelding fra prosjektleder.
Tillatelsen gjelder til 31.05.2014. Av dokumentasjonshensyn skal opplysningene likevel bevares inntil
31.05.2019. Opplysningene skal lagres avidentifisert, dvs. atskilt i en nøkkel- og en opplysningsfil.
Opplysningene skal deretter slettes eller anonymiseres, senest innen et halvt år fra denne dato.
Forskningsprosjektets data skal oppbevares forsvarlig, se personopplysningsforskriften kapittel 2, og
Helsedirektoratets veileder ”Personvern og informasjonssikkerhet i forskningsprosjekter innenfor helse- og
omsorgssektoren”
Sluttmelding og søknad om prosjektendring
Prosjektleder skal sende sluttmelding til REK sør-øst på eget skjema senest 30.11.2014, jf. hfl. §
12. Prosjektleder skal sende søknad om prosjektendring til REK sør-øst dersom det skal gjøres vesentlige
endringer i forhold til de opplysninger som er gitt i søknaden, jf. hfl. § 11.
Klageadgang
Du kan klage på komiteens vedtak, jf. forvaltningslovens § 28 flg. Klagen sendes til REK sør-øst.
Klagefristen er tre uker fra du mottar dette brevet. Dersom vedtaket opprettholdes av REK sør-øst, sendes
klagen videre til Den nasjonale forskningsetiske komité for medisin og helsefag for endelig vurdering.
Med vennlig hilsen
Grete Dyb
førsteamanuensis dr. med
Leder
Jakob Elster
Seniorrådgiver
Kopi til: seraf-admin@medisin.uio.no  

Sample size calculations 
n = 2[(a + b)2σ2] 
       (μ1 – μ2)2 
 
 
n = sample size in each group  
μ1 = domain mean in treatment group 
μ2 = domain mean in control group 
μ1 − μ2 = the difference the investigator wishes to detect; 
here the MCID of each domain 
σ2 = population variance (SD2); here using SD of domain 
mean change  
a = conventional multiplier for alpha of 0.05 
b = conventional multiplier for power of 0.80 
  
 
n = 2[(1.96+0.842)2*2.62] 
     (1.3)2 
 
n = 64 
Physical health QoL 
  
 
n = 2[(1.96+0.842)2*1.62] 
     (0.8)2 
 
n = 64 
Psychological health QoL 
  
 
n = 2[(1.96+0.842)2*2.82] 
    (1.4)2 
 
n = 64 
Social relationships QoL 
  
 
n = 2[(1.96+0.842)2*2.02] 
    (1.0)2 
 
n = 64 
Environment QoL 
 
 
